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Executive Summary 
Strategies for Uncomplicated Upper Respiratory Infections and Patient Satisfaction. 
Problem   
Overuse or inappropriate use of antibiotics is a major contributing factor to reduced drug 
efficacy, and increased prevalence of resistant pathogens. The two delayed prescription strategies 
combined with the patient education showed a promising reduction in inappropriate antibiotics 
use. However, it is not yet clear which delay prescription strategy is the most effective between 
these two strategies.  
 
Purpose 
The purpose of this QI project was to investigate if an educational program increased patients’ 
knowledge of proper antibiotic use, perceptions of severity of symptoms, their belief in 
symptomatic treatment for viral illnesses, their satisfaction in their treatment plan and the 
differences in number of antibiotic prescriptions filled for two different delayed antibiotics 
strategies designed to reduce inappropriate use of antibiotics for adult patients with 
uncomplicated URIs patients’ at an urgent care clinic in Charles County, Maryland 
Mission 
Promote appropriate antibiotic use in the adult patients with uncomplicated URIs through a 
coordinated program of education and delayed prescription strategies in an urgent care setting. 
Vision 
Encourage antibiotic stewardship through a coordinated program that promotes the appropriate 
use of antibiotic, improve patient outcomes, reduces microbial resistance and decrease the spread 
of infections caused by multidrug-resistant organisms.  
Goals 
The goals of the study were to measure the impact of an educational program on the variables 
above and compare the two different delayed prescribing strategies. 
 
Plan 
Self-report instruments were used to investigating the effectiveness in an education program to 
improve patients’ knowledge of appropriate antibiotics use and compare two different delayed 
prescribing strategies in reducing antibiotic prescriptions filled.  
 
Outcomes and Results 
The patient led delayed prescription strategy, in addition to the patient education, resulted in a 
statistically significant decreased of antibiotic prescriptions filled by subjects diagnosed with an 
uncomplicated URIs. The patients’ antibiotic use was strongly related to the severity of 
symptoms on day three.  More than 50% of the patients stating that symptomatic treatment 
helped. The perceived helpfulness of symptomatic treatment is strongly associated with 
decreased antibiotics use in this study. The educational program did not make any statistically 
significance in decreasing the use of antibiotics, but it did help to increase the patient’s 
satisfaction.   
TWO DELAYED ANTIBIOTIC PRESCRIPTION STRATEGIES 
iii 
 
Acknowledgements 
I dedicate this work to my supportive family. Thank you for your constant support, 
understanding, encouragement and love. I am very grateful for my husband and children’s 
patience and sacrifice over the last three years. You have allowed me to pursue my doctoral 
degree and reach this pinnacle of academic achievement.  
To all the staff members at the UMCC Urgent care clinic, you constant source of 
motivation and support made the completion of this project possible. 
To my project chair, Dr. Lynn Wimett (my cheerleader), you are a constant source of 
motivation and sanity throughout this process. You have mentored me with your mind and your 
heart through your compassion and commitment to my success in the DNP program. Thank you 
for always supporting and pushing me to reach this milestone.  
Lastly, thank you to the entire Regis University DNP program faculty for your 
commitment and passion to the development of future nurse leaders. I could not have done it 
without each and every one of you planting the seeds for my growth throughout the program. I 
am forever grateful to you all. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TWO DELAYED ANTIBIOTIC PRESCRIPTION STRATEGIES 
iv 
 
Table of Contents 
I. Preliminary Pages .............................................................................................. i   
A. Copyright Page....................................................................................... i 
B. Executive Summary .............................................................................. ii 
C. Acknowledgements .............................................................................. iii 
D. Table of Contents ................................................................................. iv 
E. List of Tables ...................................................................................... vii 
F. List of Appendices ............................................................................. viii 
II. Problem Recognition and Definition .................................................................1 
A. Problem ..................................................................................................1 
B. Project Purposes .....................................................................................3 
C. Project Question .....................................................................................3 
D. PICO Statements ....................................................................................3 
E. Project Significance, Scope and Rationale ............................................5 
F. Theoretical Frameworks ........................................................................6 
i. Pender’s Health Promotion Model.............................................6 
ii. Bandura’s Self-Efficacy Theory ................................................7 
iii. Prochaska’s Transtheoretical Model of Behavior Change.........7 
G. Literature Review...................................................................................8 
III. Market and Risk Analysis ............................................................................... 13 
A. Strengths, Weakness, Opportunities and Threats ................................13 
B. Driving, Restraining and Sustaining Forces ........................................15 
C. Key Stakeholders .................................................................................15 
TWO DELAYED ANTIBIOTIC PRESCRIPTION STRATEGIES 
v 
 
D. Cost-Benefit Analysis ..........................................................................16 
IV. Project Objectives ............................................................................................19 
A. Mission .................................................................................................19 
B. Vision ...................................................................................................19 
C. Project Goals ........................................................................................19 
D. Outcome Objectives .............................................................................19 
V. Evaluation Plan ................................................................................................20 
A. Participants ...........................................................................................20 
B. Definition of Variables ........................................................................21 
C. Methodology and Measurement ..........................................................21 
i. Procedures ................................................................................21 
ii. Instruments ...............................................................................25 
D. Risk Evaluation ....................................................................................27 
VI. Project Findings and Results ............................................................................29 
A. Sample Description ..............................................................................29 
B. Comparison Between Intervention One and Intervention Two ...........30 
C. Education Program Outcomes .............................................................32 
D. Impact of Education on Patient Satisfaction ........................................34 
E. Symptomatic Treatment .......................................................................36 
F. Duration and Severity of Symptoms ....................................................38 
G. Patient Satisfaction...............................................................................42 
VII. Limitations, Recommendations and Implications for Practice ........................44 
A. Limitations ...........................................................................................44 
TWO DELAYED ANTIBIOTIC PRESCRIPTION STRATEGIES 
vi 
 
B. Recommendations ................................................................................44 
C. Implications for Change .......................................................................44 
VIII. Summary ..........................................................................................................45 
IX. References ........................................................................................................46 
X. Appendices .......................................................................................................50 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TWO DELAYED ANTIBIOTIC PRESCRIPTION STRATEGIES 
vii 
 
List of Tables 
I. Market and Risk Analysis ................................................................................17 
II. Baseline Patient Characteristics .......................................................................29 
III. Antibiotic Rx Filled and Patient Satisfaction between Interventions ..............31 
IV. Filling of Antibiotic Rx Between Interventions...............................................32 
V. Education Program and Decision on Filling Antibiotic Rx ............................ 33 
VI. Rx Filled and Education’s Effect on Decision .................................................34 
VII. Patient’s Satisfaction and Education ................................................................36 
VIII. Symptomatic treatment and Filling Antibiotic Rx ...........................................37 
IX. Perceived Helpfulness of Antibiotic and Day Rx Filled ..................................38 
X. Severity of Symptoms on Day Zero Between Intervention Groups ................39 
XI. Severity of Symptoms on Day Three Between Intervention Groups ..............39  
XII. Severity of Symptoms on Day Seven Between Intervention Groups ..............40  
XIII. Severity of Symptoms on Day Ten Between Intervention Groups..................40 
XIV. Difference with Antibiotics Used and The Severity of Symptoms ..................41 
XV. Patient Satisfaction between Interventions ......................................................43 
XVI. Patient Satisfaction between Intervention ranking ..........................................43 
 
 
 
 
 
 
TWO DELAYED ANTIBIOTIC PRESCRIPTION STRATEGIES 
viii 
 
List of Appendices 
A. What Everyone Should Know and Facts about Antibiotics .............................50 
B. Symptomatic Prescription Rx ..........................................................................53 
C. Delay Antibiotics Prescription  ........................................................................54  
D.  Patient Collection Strategy .............................................................................55 
E. CITI Training Certificate .................................................................................56 
F. Informed Consent.............................................................................................58 
G.  Enrollment Sheet .............................................................................................63  
H. Follow Up Response Form ..............................................................................64 
I. Letter of Agreement from Urgent Care Clinic .................................................65 
J. Regis University IRB Approval .......................................................................67 
K. Get Smart Antibiotic Quiz ...............................................................................68 
L. WURSS-21 ......................................................................................................70 
M. Logic Model .....................................................................................................71 
N. DNP Project Timeline ......................................................................................72 
 
 
 
TWO DELAYED ANTIBIOTIC PRESCRIPTION STRATEGIES 
1 
 
Strategy for Uncomplicated Upper Respiratory Infections and Patient Satisfaction. 
Problem Recognition and Definition 
Problem  
Overuse or inappropriate use of antibiotics, particularly broad-spectrum antibiotics, in 
primary care is a major contributing factor to reduced drug efficacy, increase prevalence of 
resistant pathogens in the community, and escalate the appearance of new co-infections (Arroll, 
Goodyear-Smith, Thomas and Kerse, 2013; Dekker, Verheij, Van and Velden, 2015). The factors 
contributing to inappropriate antibiotics use include patient demand, lack of education on proper 
antibiotics use, perceived duration of illness, lack of diagnostic that lead to diagnostic 
uncertainty; attempting to provide something to mitigate symptoms making the person miserable, 
trying to decrease the length of time for office visit and increasing patients’ satisfaction (Arroll, 
et al., 2013; Avent, et al., 2016; De la Poza et al., 2016; Hoffmann & Del Mar, 2015; Saleem, et 
al., 2016). In fact, patient demand is a driving force.  
About 53% of all patients’ seeking urgent care for the evaluation of viral symptoms 
requesting or expecting to receive antibiotics prescriptions for their symptoms. This too often 
results in the primary care clinicians prescribing antibiotics despite strong evidence that 
antibiotics typically provide no benefits at all for viral pathology (Vervloet, et al., 2016) and 
without consideration of antibiotics resistance developing. This has become a global public 
health crisis (World Health Organization, 2013) with the slow development of new antibiotics 
(Al-Tawfiq & Alawami, 2017) to replace those that are no longer effective. Al-Tawfiq & 
Alawami (2017) reported in Saudi Arabia, a 13.2% resistance to ampicillin for Haemophilus 
influenzae and 59% resistance to penicillin for Streptococcus pneumonia. To make matters 
worse, according to the Center of Disease Control (CDC, 2014) a growing number pathology of 
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healthcare-associated infections are caused by bacteria that are resistant to multiple antibiotics. 
These include: MRSA, vancomycin-resistant Enterococcus, extended-spectrum cephalosporin-
resistant K. pneumonia (and K. oxytoca), E. coli and Enterobacter spp., carbapenem-resistant P. 
aeruginosa, carbapenem-resistant K. pneumonia (and K. oxytoca), E. coli, and Enterobacter spp. 
In order to decrease the development of antimicrobial resistance, patients, healthcare providers, 
healthcare facility administrators, and the policy makers must work together to employ effective 
strategies to prevent inappropriate use of antibiotics.  
Durante, McBride, Miklo, Killeen, & Creech (2017) studied different methodologies used 
to limit the use of antibiotics in adults with uncomplicated upper respiratory infections (URIs), 
including delayed antibiotics prescribing, providing education to clinicians, and the use of 
laboratory tests to justify efficacy of antibiotics intervention. They found delayed prescription 
writing alone could result in a 52% reduction in inappropriate antibiotics use, and when 
education on symptoms was added, a further reduction (64%) was noted. Several studies (Arroll, 
et al., 2013; De la Poza et al., 2016; Høye, Gjelstad, & Lindbæk, 2013; Coxeter, Del Mar, 
McGregor, Beller, & Hoffmann, 2015; Vervloet, et al., 2016) also suggested that delayed 
antibiotics prescriptions help to reduce antibiotics use without damaging effects when used with 
reasonable symptom control. The delayed prescription strategies also showed high potential for 
decreasing inappropriate use of antibiotics without decreased clinical benefit in several European 
and Asian countries, as well as the United States (Arroll, et al., 2013; De la Poza et al., 2016; 
Høye, Gjelstad, & Lindbæk, 2013; Coxeter et al., 2015; Vervloet, et al., 2016).  
Delayed prescription strategies consist of prescribing an antibiotics but directing the 
clients to only fill the prescription if the symptoms worsen after they started to get better or if 
there is no improvement in symptoms in seven to ten days.  However, it is not yet clear which 
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delay prescription strategy is the most effective between these two strategies (Arroll, et al., 2013; 
De la Poza et al., 2016; Høye, Gjelstad, & Lindbæk, 2013; Vervloet, et al., 2016). De la Poza et 
al., (2016), concluded that the efficacy between the two delayed prescription strategies should be 
evaluated in different settings and populations. 
Project Purposes 
The purpose of this QI project was to investigate the efficacy of an educational program 
in improving patients’ knowledge of proper antibiotic use, their belief in symptomatic treatment 
for viral illnesses, the patient’s perception on the severity of symptoms, the effectiveness 
between the two delayed antibiotics strategies designed to reduce inappropriate use of antibiotics 
for adult patients with uncomplicated URIs (cold symptoms, influenza, sore throat, bronchitis, 
cough and nasal congestion) and the patients’ satisfaction in their treatment plan at an urgent 
care clinic in Charles County, Maryland.   
Project Question 
The project question was: Would there be a difference for inappropriate antibiotic use in 
adults who presented with URI symptoms when an education program that included proper 
antibiotic use and symptomatic treatment was offered in addition to one of the two delayed 
prescription strategies while maintaining patient satisfaction?  
PICO Statements 
Population. Adult patients (18-65) with URIs symptoms seeking care at the urgent care 
clinic. 
 Interventions. Patient led delayed prescription strategy. Collection delayed prescription 
strategy and an education program 
 Comparison. Difference in number of antibiotic prescriptions filled between the patient 
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led delayed prescription strategy and the collection delayed prescription strategy. Comparison of 
knowledge of symptomatic treatment, severity of symptoms, need for antibiotic use before and 
after education, and patient satisfaction differences between the patient led delayed prescription 
strategy and the collection delayed prescription strategy. 
 Outcome. Difference in number of antibiotic prescriptions filled between the patient led 
delayed prescription strategy and the collection delayed prescription strategy. Differences in 
knowledge of symptomatic treatment, severity of symptoms, need for antibiotic use before and 
after the education intervention. Patient satisfaction differences between the patient led delayed 
prescription strategy and the collection delayed prescription strategy  
 Population  
Adult between the ages of 18-65 who presented with URI symptoms to an urgent care 
clinic for treatment. 
Intervention One. The patient led delayed prescription strategy. Patients seeking care for 
an uncomplicated URI, assigned to this intervention, were given a prescription for an antibiotic 
appropriate for a possible bacterial infection based on URI history, and physical examination 
findings and the provider’s preference. Patients in this arm or the study were told they could fill 
the antibiotics prescriptions at any time but were encouraged to fill their prescriptions only if 
their symptoms were not improved or worsened in ten days after the initial symptoms.  
Intervention Two.  The collection delayed prescription strategy. Adults seeking care for 
an uncomplicated URI received the same anticipatory and educational material as those 
participating in intervention one; however, these patients were told they had to return to the 
clinic for their antibiotic prescriptions if their symptoms were not improved or had worsened ten 
days from the onset of their symptoms.  
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Project Significance, Scope and Rationale 
 The rapidly increasing rate of antimicrobial resistance to superbugs threatened patients who 
were suffering from multiple antimicrobial resistant bacterial infections. The annual mortality 
from drug-resistant bacteria may exceed 10 million by 2050 (Spinks et al., 2013). The Centers 
for Disease Control and Prevention (CDC) reported 266.1 million antibiotics prescriptions were 
filled by the local pharmacies in the U.S. and the most common conditions for which antibiotics 
were prescribed in ambulatory care settings were for acute URIs (Ahovuo-Saloranta et al., 2014; 
Spinks et al., 2013), despite clear evidence, these conditions were mostly viral in origin, and 
antibiotics did not help, but their inappropriate use not only increased resistance to these drugs 
but also strained resources, placed patients at risk of adverse effects, and increased the number of 
future consultations for similar episodes (De La Poza et al., 2016; Drekonja et al., 2015). This 
led to the White House (2015) releasing a national action plan for reducing inappropriate 
outpatient antibiotics by 50 percent. The national action plan provided a roadmap that outlines 
federal activities over the next five years. This plan was designed to enhance domestic and 
international capacity to prevent and contain outbreaks of antibiotics-resistant infections; 
maintain the efficacy of current and new antibiotics; and develop and deploy next-generation 
diagnostics, antibiotics, vaccines, and other therapeutics.  This issue was so critical, the 
President’s 2016 budget included more than $1.2 billion dollars, nearly double from last year 
to combat and prevent antibiotics resistance. We must find effective interventions to reduce 
inappropriate antibiotics use, such as delayed prescribing strategies, that can be used in 
ambulatory care settings to decrease inappropriate antibiotics use (Coxeter et al., 2015; 
Drekonja et al., 2015). Delayed antibiotics prescription helps to reduce antibiotics use in the 
uncomplicated URIs patients. De La Poza Abad et al. (2016) suggested that while there were 
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different strategies of delayed prescription, it was not clear which one was most effective. The 
objective of this project was to investigate the efficacy of two delayed prescription strategies in 
patients with uncomplicated URIs and measure the effectiveness of an educational program in 
improving patients’ knowledge of proper antibiotic use, their satisfaction in their treatment plan, 
and their belief in symptomatic treatment for viral illnesses.  This project was a quality 
improvement initiative project based on evidence based practice. Developing new knowledge or 
for the findings to be generalized outside of the urgent care study population were not the 
intention of this project.  
Theoretical Frameworks 
 Pender’s Health Promotion Model (HPM). The Health Promotion Model (HPM) of Nola 
Pender (2011) stated that an action or decision made by an individual was affected by their 
personal characteristics, knowledge and experiences. Health promoting behaviors that improved 
health, functional ability and quality of life at all stages of development were the desired 
behavioral outcome of the HPM. The major assumption of the theory was that an individual was 
constantly and actively interacting with the environment (Pender). He stated that individuals 
were willing to adopt new behaviors, modify physical environment and thought process to take 
actions leading to perceived rewarding or desired health outcomes. Applying Pender’s HPM 
concepts to this study suggested that the patients would be receptive to the symptomatic 
management of a viral illness and reduce demand for inappropriate antibiotic use if they 
understand that antibiotics are not only ineffective for uncomplicated URIs but the misuse of 
antibiotics led to the development of antibiotics-resistant bacteria.  
Bandura’s Self-Efficacy Theory (1997).  Bandura described and explained the relationship 
between one's beliefs and one’s ability to implement situation specific behaviors to attain 
TWO DELAYED ANTIBIOTIC PRESCRIPTION STRATEGIES 
7 
 
established goals, expectations, or designated types of outcomes. Perceived self-efficacy beliefs 
were considered to be central and persuasive factors in determining the course of action selected 
the degree of effort exerted, and the perseverance to continue in the face of difficulties and 
setbacks. Based on Bandura’s research, for this study, patients who strongly believed that the 
antibiotics were not the answer to their illness, the longer they were willing to try symptomatic 
management of a viral illness instead of filling the antibiotics prescriptions as soon as they could. 
For this reason, all patients received education on why viral illness should not be treated with an 
antibiotic and how they could treat the symptoms of a viral illness without antibiotics 
prescription (see Appendix B). 
Prochaska’s Transtheoretical Model of Behavior Change. Prochaska (Prochaska et al., 
2002) suggested that the health behavior change involved progression through six stages of 
change: precontemplation, contemplation, preparation, action, maintenance, and termination. 
Individuals often change behavior for a variety of reasons however, after a period of time, they 
revert to their old ways unless motivators and values become firmly rooted and norms that 
support lasting change are established within populations (Prochaska, Prochaska & Levesque, 
2001). The Transtheoretical Model illustrates that human behavior change rarely progresses in a 
straightforward fashion and then easily locks into place (Prochaska et al.). In order to achieve 
sustainability of the antibiotics stewardship program, almost all previous antibiotics initiatives 
had been grounded in a traditional, information-intensive health education approach that relied 
heavily on knowledge leading to attitude change that in turn led to lasting behavioral 
transformation. The goal of all programs was sustainability (Prochaska et al.). Prochaska’s 
Transtheoretical Model of Behavior Change provided the framework for driving the change for 
inappropriate antibiotic use. 
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Literature Review 
 A literature search was conducted using the electronic databases of Academic Search 
Premier, Cumulative Index to Nursing and Allied Health Literature Complete (CINAHL), 
MEDLINE, and PsycINFO through the Regis University, Google Scholar, PubMed, and 
Cochrane Library. Search teams included antibiotics treatment, antibiotics resistance, delayed 
antibiotics strategies, ambulatory care, family practice, urgent care, emergency 
department, primary care, respiratory tract infections. This search yielded 313,399 results from 
Academic Search Premier, CINAHL, psynINFO and MEDLINE. To narrow down the search, 
exclusions included duplicate articles, non-English articles and publication dated between the 
years of 2013-2017. This resulted in 97,105 articles. Using the same limits and keywords with 
exclusion to adult patients, full text, scholarly (peer reviewed) journals, academic journals, 
randomized controlled trials (RCT); adding additional limits including randomized controlled 
trials (RCT), meta-analysis and reviews, the results yielded 168 results. According to the 
National Health and Medical Research Council (NHMRC) Evidence Hierarchy (2013), RCT, 
meta-analysis and reviews were at the top of the pyramid and ranks as the highest level I 
evidence where the best evidence is located.  To further narrow down the search, key words were 
limited to delayed prescription strategy and uncomplicated upper respiratory. This yielded 41 
articles again using the search engines Academic Search Premier, CINAHL, PsynINFO and 
MEDLINE. Further limiting the keywords to delayed prescription strategy and patient 
satisfaction decreased article to 12. Changing the limit to delayed prescription strategy and 
efficacy yielded an additional four articles; using delayed prescription strategy and antibiotics 
use yielded 17 articles. Limiting the search to delayed prescription strategy and patient education 
yielded another four articles, and fusing delayed prescription strategy and follow up yielded 
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another four articles. Three systematic reviews and meta-Analysis on antibiotics use and URIs 
from the Cochrane Database System Review were reviewed. Together a total of 27 articles were 
reviewed and applied to develop this project.  
The emerging themes from reviewing the 27 applicable articles were: 1) delayed 
prescriptions strategies helped to decrease antibiotics use in the patients with uncomplicated 
URIs. 2) Provider’s explanation and education reinforced to efficacy of the strategies to decrease 
inappropriate antibiotics use 3) patients’ satisfaction was not related to antibiotics prescriptions 
but to their understanding of the disease process and perception of the providers spending time 
with them. There was a gap in the literature as to the efficacy between the two delayed 
prescription strategies and population of patients presenting at urgent care outpatient clinics.   
 For the past twenty years, many interventions showed driving forces to decrease 
inappropriate antibiotics use included targeting physicians and patients. Successful strategies 
included education, physician audit and feedback, delayed prescribing strategies, financial 
incentives to providers and patients, and health information technologies (Butler et al., 2013; De 
la Poza et al., 2016; Glasziou, 2016; Little et al., 2014; Ryan et al., 2014; Sargent 2016; 
Shaughnessy, 2016). Restraining forces included expressed patient pressure for antibiotics and 
concern over patient satisfaction scores when antibiotics were not prescribed. (Ahovuo-Saloranta 
et al., 2014; Coxeter et al., 2015; De la Poza et al., 2016; Harris, Hicks, & Qaseem, 2016; 
Lindbæk, 2014; Little et al., 2014; Ryan et al., 2014; Yang, Liu, Wang, Yin, & Zhang, 2014). 
However, further studies emphasized patient satisfaction depends more on the patient-centered 
quality of the encounter, such as the provider spending enough time with the patient to explain 
the patient's illness, than on the receipt of an antibiotics prescription (Agnew, Taaffe, Darker, 
O'Shea, & Clarke, 2013; De la Poza et al., 2016; Glasziou, 2016; Ryan et al., 2014). To 
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capitalized on this driving force, i.e. to increase patient satisfaction and decrease antibiotics 
prescriptions for uncomplicated URIs, research suggested providers can promote appropriate 
antibiotics use by labeling acute bronchitis as a “chest cold” or “viral upper respiratory infection” 
to emphasize viral origin of pathology and then providing patient information sheets about 
alternatives to antibiotics for managing symptoms of viral infection (Coxeter et al., 2015; De la 
Poza et al., 2016; Shaughnessy, 2016, Yang et al., 2014; ).  
 According to Butler, Rollnick, Pill, Maggs-Rapport & Stott (2013), patients who expected 
antibiotics and when the providers perceived that patients expect antibiotics they were10 times 
more likely to be prescribed. General practitioners describe this as the most uncomfortable 
decision about prescribing that they make. Antibiotics prescribing was rising in primary care, 
especially for respiratory tract conditions (Barlam et al., 2015). There were growing concerns 
about cost, increasing workload for these usually self-limiting conditions  and the rising 
prevalence of antibiotics resistant bacteria (Arroll, et al., 2013; Avent, et al., 2016; Barlam et al., 
2015; Butler et al., 2013; and De la Poza et al., 2016). This health concern could be targeted not 
only at providers, but also at the patients’ level. Collaboration between patient and provider 
required that each individual brought their expertise and expectation to the forefront and work 
together for a common positive outcome (Zaccagnini & White, 2014).   
Multiple studies (Coxeter et al., 2015; De la Poza et al., 2016; Lecky, Hawking, Quigley, 
& Butler, 2015;  McNulty et al., 2015; Ryan et al., 2014; Shaughnessy, 2016) disclosed a 
decrease in antibiotics prescribing for uncomplicated URIs and increased satisfaction ratings 
when providers gave advice on symptomatic therapy and explained why antibiotics were not 
needed for uncomplicated URIs. Providing a symptomatic prescription pad used to provide 
recommendations for management of symptoms without antibiotics, allowed patients to walk 
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away with a plan of action that did not include inappropriate antibiotics (De la Poza et al., 2016; 
Little et al., 2014; Sargent, McCullough, Del Mar, & Lowe, 2016).  
Another strategy according to the Antibiotics: the Spanish strategy (2016), when it was 
unclear whether an antibiotics was needed, was to delay or postdate antibiotics prescriptions with 
watchful waiting or the wait-and-see approach and offer the possibility of future antibiotics 
treatment if the condition did not improve or worsen. This delayed antibiotics prescriptions 
strategy was also shown to increase patient satisfaction and decrease antibiotics use (Butler et al., 
2013; De la Poza et al., 2016; Glasziou, 2016; Little et al., 2014; Ryan et al., 2014; Sargent 2016; 
Shaughnessy, 2016) and did not result in poor symptom control or clinically significant 
complications of respiratory infections (Arroll, et al., 2013; Coxeter et al., 2015; De la Poza et 
al., 2016; Del Mar, Dooley, and Foxlee, 2013; Lecky et al., 2015; Little et al., 2014; McNulty et 
al., 2015; Ryan et al., 2014; Shaughnessy, 2016).  
Two methods to delay antibiotics use studied differed slightly. One method was to allow 
patients to collect the prescription from the clinic when symptoms were not self-limiting within 
seven to ten days (collection), and another method was patient led strategy. The provider was to 
give prescriptions to patients during the initial visit but asking them to wait to fill the prescription 
in seven to ten days if the symptoms did not resolve and/or if the symptoms worsened (Agnew et 
al., 2013; Barlam, Morgan, Wetzler, Christiansen & Drainoni, 2015; Little et al., 2014; McNulty 
et al., 2015).  
A few studies on acute sore throat and URIs have suggested that an immediate 
prescription or delayed antibiotics prescription could reduce return office visits compared with a 
no prescription strategy but the trials were underpowered to compare efficacy between strategies 
and to be generalized for the larger population (Arroll, et al., 2013; De la Poza et al., 2016; 
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Drekonja et al., 2015; Little et al., 2014; Spurling et al., 2013). No articles comparing between 
the two different delayed prescription strategies to delay patients from filling the antibiotics 
prescription were found.  
 However, studies revealed that the severity of symptoms and the duration of symptoms were 
the same for patients who received immediate antibiotics compared to those who were not started 
on antibiotics immediately. Satisfaction was similar across groups (Arroll, et al., 2013; Coxeter 
et al., 2015; Lecky et al., 2015; Little et al., 2014; McNulty et al., 2015; Shaughnessy, 2016;  
Spurling, Del Mar, Dooley, and Foxlee, 2013; Ryan et al., 2014).  
Studies did show that the perceptions that antibiotics had no effect or were not very 
effective was higher for patients in the two delayed antibiotics strategies and the no antibiotics 
strategy compared to the immediate prescription strategy (Spurling et al., 2013; McNulty et al., 
2015; Lecky et al., 2015; Shaughnessy, 2016; Ryan et al., 2014) and the delayed prescription 
strategies reduced antibiotics use when compared with an immediate strategy (Agnew et al., 
2013; Barlam, Morgan, Wetzler, Christiansen & Drainoni, 2015; De la Poza et al., 2016;  Little 
et al., 2014; McNulty et al., 2015).  No differences were observed for complications, adverse 
effects, or the need for unscheduled care among the strategy groups, and no differences were 
observed in the perception of general health status (Arroll, et al., 2013; De la Poza et al., 2016; 
Drekonja et al., 2015; Little et al., 2014; Spurling et al., 2013). 
 Several studies (Agnew et al., 2013; De la Poza et al., 2016; Durante et al., 2017; Little et al., 
2014) suggested that the combination effect of delayed antibiotics prescription and education 
compared to delayed antibiotics prescription alone were more effective to decrease inappropriate 
use of antibiotics. In fact, a study by Agnew et al (2013) suggested that the patient education 
material such as an education leaflets in addition to delayed prescription decreased the rate of 
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inappropriate antibiotics use from 72% to 43%; however several studies concluded that more 
studies are necessary to demonstrate the efficacy between the two delayed prescription strategies 
in different settings and patient populations (Agnew et al., 2013; De la Poza et al., 2016; Little et 
al., 2014). 
 While delayed prescribing was not a perfect solution, it did compromise between an 
immediate prescription and a no prescription strategy. As such, even though some patients would 
still receive unnecessary antibiotics using a delayed prescription strategy, the evidence suggested 
these strategies did significantly reduce antibiotics overuse and therefore should be embraced. 
The challenge remained for researchers to define exactly what was involved in delayed 
prescribing, and how clinicians could use it in different practice contexts (Little et al., 2014; De 
la Poza et al., 2016). 
Market and Risk Analysis 
Strengths, Weakness, Opportunities and Threats  
A SWOT analysis was completed so that the strength and opportunities of this project 
could be uncovered and exploited. The identified weakness and threats to this project were 
eliminated when possible and minimized when it was not possible to eliminate them entirely.  
Strength. One of the strength of this project was the support from the urgent care clinic 
where the project will take place. The urgent care clinic is new with state of the art medical 
equipment. It was certified by The Joint Commission since September 2015. The medical 
director and manager of the urgent clinic were supportive and provided the target population for 
the project. The staff members (providers and medical assistants) were participated in the project 
at no additional cost. The office manager offered flex clinic times to free up clinical staff to help 
with the project. Seventy-seven percent of the study participants rated the experience as satisfied 
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to very satisfied. In addition to that this project established an environment of support, trust and 
co-operative learning between providers, medical assistants and managers. It makes the mundane 
clinic challenging, interesting, motivating, engaging, and fun. It has been a great team building 
experience. 
Weakness. The disruptions in the continuity of care, as the staff members were distracted 
from their involvement in the project. Longer office visit for the project participants compared to 
the regular patient visits. Since the longer office visit was explained in the consent forms, all the 
study participants understood of the longer than usual visit. The role confusion of the staff 
members was addressed by regular meetings and discussions. Insufficient training on data 
collection and other research related processes were addressed with timely training sessions.  
Opportunities.  Opportunities are defined as the external factors that are likely to have a 
positive effect on achieving or exceeding the clinic’s objectives, or goals not previously 
considered (Zaccagnini & White, 2014). This project has reduced the use of antibiotics in the 
patients with uncomplicated URIs by 25% and directly decrease cost to the health insurance 
companies. All 67 study participants expressed favorable views of the delayed antibiotic 
strategies.  
Threats. Losing patients to another clinic was one of the threats of this project. However, 
53 of the 67 participants (79%) did not seek help at another clinic. Only seven patients went to at 
another clinic for evaluation. The concern of potential revenue loss of the hospital pharmacy was 
not founded since the sample size for the study was only 67 patients.  
Driving, Restraining and Sustaining Forces 
Driving forces. One of the most significant driving forces for this project was the 
overwhelming evidence from numerous clinical trials suggested the ineffectiveness of antibiotics 
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for uncomplicated URIs but the risk of antibiotics resistant bacteria when antibiotics were used 
inappropriately (Ahovuo-Saloranta et al., 2014; CDC 2014; Spinks et al., 2013). The risk of 
emerging antibiotics resistance bacteria included not only greater costs to the health care system 
but increased mortality and morbidity (Coxeter et al., 2015; Drekonja et al., 2015). Another 
driving force was the gap in the literature as to what methods are most efficient and effective in 
reducing inappropriate use of antibiotics. Numerous studies concluded education and delayed 
prescriptions were helpful but that additional study was essential (Agnew et al., 2013; De la Poza 
et al., 2016; Little et al., 2014). Another driving force was the approval and support from the 
quality improvement team of the urgent care clinic that agreed to support the project and the care 
providers recognizing the benefits from the study and willingly participating in the study. 
Restraining forces. Restraining forces for this project included the limited time to 
conduct the project, the lack of monetary incentive for participants, the time commitment to 
already burdened staff, fear of liability and cultural and institutional inertia. One of the providers 
from another clinic mentioned that if a patient expressed the desire for an antibiotic, it was best 
to give out the antibiotics prescription “without arguing with the patient.” The belief was that this 
would decrease patient complaints, return visits and loss of patients to another urgent care clinic. 
Key Stakeholders 
The stakeholders of this project were patients, potential patients who may benefit from a 
decrease in bacterial resistant antibiotics, insurance company that may appreciate a decrease in 
cost of care with decrease in unnecessary antibiotics use, the urgent care clinic staff including 
two physicians, one nurse practitioners (NP), four medical assistants (MAs), and the quality 
assurance team of the urgent care clinic. Although this QI project could not be generalized, the 
findings might lead to additional studies that could benefit future patients and other stakeholders 
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mentioned above. The project team, also key stakeholders, included the lead researcher, the two 
physicians, four MAs the project mentor (NP), the project advisor and the pharmacists at the 
hospital pharmacy.    
Cost-Benefit Analysis 
Cost for this project was minimal because of the donation of the clinic and staff for the 
place, equipment, and time; however, should this project be duplicated or continued, staff 
resources would cost approximately $29,830. The need and the resources to conduct the project 
include the involvement of three providers (two physicians and one nurse practitioner), four 
medical assistants, exam rooms, equipment to obtain vital signs. The CDC’s (2016) “Get Smart 
about Antibiotics” program was designed to educating the patients in danger of inappropriate use 
of antibiotics. It was free of charge and included posters, brochures, and a viral medical (Rx) 
prescriptions. The use of the telephone, CDC handouts, exam room and equipment to obtain 
patients’ vital signs did not add any additional cost to the clinic but if duplicated would cost $45-
$50.  The estimate for the cost of paper and printing (data collecting sheets, inform consents, 
duplications handouts from the CDCs and etc.) for this project was $50.  The urgent care clinic 
saw about 30-40 patients daily. About half of the visits were for evaluation of URI symptoms 
and three to five people per day fit all the inclusion criteria. The time to recruit and enroll a 
patient into the study was 30 minutes. A complementary 30 minutes follow up visit was offered 
to all the participants. Fifty-seven of the 67 patients returned for the complementary visit making 
the total time per participant one hour. Sixty seven participants x 0.5 hour (screening) and 57 
patients returned for the complementary visit x 0.5 hours. The total additional time the providers 
spent with the study participants was 63.5 hours. The additional hours divided among the three 
providers calculated to 21.16 hours per provider. The MAs that sent reminder emails and texts to 
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patients on day three and day seven, scheduled complementary follow up appointment, notify the 
providers that study participants desired antibiotics prescriptions, and put antibiotic prescriptions 
to front desk for the patients to pick up were calculated to be 50 hours. The principal investigator 
spent approximately 200 hours on planning, meetings; preparing documents and write-up of the 
project making the cost of duplicating this study $28,846 (see Table 1). 
Table 1 
Market and Risk Analysis 
Item  Cost 
Physicians $120/hour x 21.1 hours x 2 physicians 
$5064 
Nurse Practitioners $88/hour x 21.1 hours  
$1856 
Medical Assistant $14/hour x 50 hours 
$700 
Principal Investigator $88 x 200 
$17,600 
Printing, paper $50 
Complementary office visit $80 (rate for follow up visit) x 57 participants 
$4560 
Total $29,830 
 
One cost that was not well documented was the economic burden of caring for clients 
that were infected with antibiotics resistant bacteria (Kesselheim, Avorn & Sarpatwari, 2016). 
This makes it very difficult to judge the cost benefit of decreasing inappropriate use of 
antibiotics. Research showned that drug resistance bacteria increase mortality (Bjerrum, 2014; 
Kesselheim et al., 2016; Lindbæk, 2014) and premature deaths caused by antibiotics resistant 
bacteria reduced the size of the working age population (Llor & Bjerrum, 2014; Kesselheim et 
al., 2016; Lindbæk, 2014). Drug resistant bacteria also increase morbidity by causing prolonged 
disability from illness and again, a reduction in the size of workforce and productivity. In 
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addition, increased morbidity of the dependents may require the productive members of the 
family to act as care givers who would otherwise be economically productive. There was no cost 
estimate of decrease quality of life for the disabled or for care provider fatigue.   
Lindbæk, (2014) added that if resistance rates increase substantially, it could result in 
further indirect costs such as people choosing not to undergo certain medical procedures because 
of the heightened risks involved or refraining from undertaking certain activities, such as travel 
and trade. Lindbæk also suggested some people might experience general negative psychological 
effects or even panic further adding to the cost of health care and decrease in quality of life.  
 Michaelidis et al (2016) used published data to develop point and range estimates for the 
hidden societal cost of antibiotics resistance (SCAR) attributable to each ambulatory antibiotics 
prescription in the United States.  The published data on the antibiotics-resistance associated 
costs of hospitalization, second-line inpatient antibiotics use, second-line outpatient antibiotics 
use, and antibiotics stewardship were explored. The total SCAR attributable to each ambulatory 
antibiotics prescription was estimated to be $13.09 or almost 70% of the total SCAR was the cost 
of hospitalization (Michaelidis et al., 2016). The second-line outpatient antibiotics use was 15 % 
of the total SCAR at $2.  The costs of second-line inpatient antibiotics use were $1 or 8 % of the 
total SCAR, and antibiotics stewardship was the same as the inpatient antibiotics at $1 or 8%.  If 
an average antibiotics cost was $30, the total SCAR attributable to each ambulatory antibiotic 
prescription would increase antibiotics costs by 65 % to $49.50 if incorporated into antibiotics 
costs paid by patients or payers (Michaelidis et al., 2016).  
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Project Objectives 
Mission 
Promote appropriate antibiotic use in the adult patients with uncomplicated URIs through 
a coordinated program of education and delayed prescription strategies in an urgent care setting. 
Vision 
Encourage antibiotic stewardship through a coordinated program that promotes the 
appropriate use of antibiotics, improve patient outcomes, reduces microbial resistance and 
decrease the spread of infections caused by multidrug-resistant organisms.  
Project Goals 
The goals of this project were to analyze difference in number of antibiotic prescriptions 
filled between the patient led delayed prescription strategy and the collection delayed 
prescription strategy. Comparison of knowledge of symptomatic treatment, severity of 
symptoms, need for antibiotic use for viral illness before and after the education intervention and 
patient satisfaction differences between the patient led delayed prescription strategy and the 
collection delayed prescription strategy. 
  This project was a quality improvement initiative project and was not designed to 
develop new knowledge or for findings to generalize outside of the urgent care study population. 
Outcome Objectives 
The objectives of this project were to measure: 1) the differences in number of antibiotics 
used for subjects assigned to intervention one and those assigned to intervention two; 2) the 
knowledge of symptomatic treatment, severity of symptoms, need for antibiotic use for viral  
illness before and after the education intervention; 3) patient Satisfaction differences between the 
two delayed prescription strategies (see Appendix I). 
TWO DELAYED ANTIBIOTIC PRESCRIPTION STRATEGIES 
20 
 
Evaluation Plan 
Participants 
Clinical staff. Two board certified emergency medicine physicians, one nurse 
practitioner, and four medical assistants at an urgent care clinic located in Charles County 
Maryland participated in collecting data for this project. 
Subjects. Adult patients, ages 18-65 presenting to the urgent care clinic with the final 
diagnosis of uncomplicated URIs, were in general good health with no significant comorbidities 
such as uncontrolled diabetes, blood pressure, active cancer, poorly controlled psychiatric 
disorders and that require specialists’ management or referral were be invited to participate in 
this project; unless, for any reasons, a care provider felt delaying antibiotics would not be in the 
patient’s best interest. In that case, the patient not invited to participate in the project. Other 
inclusions criteria included subject’s fluent in speaking and reading English with no history of 
significant comorbidities defined below. In addition to that, the subject had no documented 
allergy to acetaminophen or ibuprofen, was immunosuppressed, or was breast feedings.  A 
written consent form was obtained from all participants.  
The project lead investigator (PI) and the faculty mentor completed CITI training (see 
Appendix E). This project was approved by the clinical director of the urgent care clinic (see 
Appendix I) and approved by the Regis University Institutional Review Board (see Appendix L).  
Definition of Variables 
 Uncomplicated upper respiratory infections. The International Classification of Diseases, 
Tenth Revision, Clinical Modification (ICD-10-CM) coding system was used to classify 
diagnoses and symptoms. For inclusion in the project, patients had to be coded for acute 
pharyngitis, rhinosinusitis, acute bronchitis, cold, influenza, or viral syndrome without 
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complications. 
 Significant comorbidities. Uncontrolled diabetes or hypertension, cancer, poorly controlled 
psychiatric disorders, require specialists’ management or referral, history of asthma, an active 
gastric ulcer disease, require hospital admission for meningitis, pneumonia, epiglottitis or 
Kawasaki disease, were febrile, unable to tolerate oral fluid, have respiratory rate of greater than 
20, an oxygen saturation level of < 92% on room air and signs of using accessory muscles for 
breathing.  
 Vulnerable population. Fetuses, pregnant women, children, prisoners, and institutionalized 
individuals will be included in this project.  
Methodology and Measurement 
Procedures. All adult patients that documented, on a clinic form, their reason for seeking 
care as any one or combination of URI symptoms (e.g., cough, earache, nasal congestion, sinus 
problems, sore throat) currently were asked to complete a simple quiz (see Appendix K) to assess 
their knowledge of when antibiotics could be effective and when they would be inappropriate to 
use. The patients returned the completed quiz to their provider during the office visit, and the 
provider kept it with the patients’ records. The provider completed and documented the patient’s 
history, results of the physical examination, diagnosis, plan of care and coded the diagnoses and 
symptoms using the ICD-10-CM coding system. If a patient’s other diagnosis was coded as acute 
pharyngitis, rhinosinusitis, acute bronchitis, cold, influenza, or viral syndrome without 
complications, the provider reviewed the completed quiz with the patient and gave the patient the 
educational brochure What Everyone Should Know and Facts about Antibiotics (CDC, 2017) 
[see Appendix A]. Then discussed with the patient the answers on the quiz and key points of the 
brochure.  
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Next, the provider explained the differences between a viral and a bacterial infection, 
symptomatic treatment for a viral illness and how inappropriate antibiotics use could lead to 
antibiotics resistance and the development of super infections that no longer respond to 
antibiotics.  Finally, the provider shared the usual course of a viral illness emphasizing it was 
normal to feel worse rather than better over the first one or two days after the onset of the URI 
symptoms. A Symptomatic Prescription developed by the CDC (2016), for use by the care 
provider was given to the patient (see Appendix B).  This Symptomatic Prescription suggested 
various over-the-counter medications and treatments for symptom relief such as 
dextromethorphan, a cough suppressant; guaifenesin, a mucus-thinning expectorant; saline nasal 
spray and humidification and Tylenol and/or Motrin for pain and fever relief. The provider 
clarified best options for the client knowing the patient’s history and symptoms and reassured 
that at this time antibiotics were not needed immediately and if taken now could cause harm 
without decreasing the symptoms or course of the illness.  
All the URI patients received the similar anticipatory guidance as described above since 
the literature was clear that education was essential to help decrease inappropriate use of 
antibiotics. No antibiotics were prescribed to treat an uncomplicated URI; however, patients 
were advised to schedule a follow-up visit if new symptoms presented that were not expected 
from a viral illness or if symptoms worsened, after the patient started to feel better. At this time, 
the patient retook the CDC’s (2016) Get Smart with Antibiotics Quiz to assess the patient’s 
understanding of appropriate antibiotics use after the teaching session. A 75% (six out of eight 
questions answered correctly) on the post-quiz Get Smart About Antibiotics Quiz suggested the 
patient understood appropriate antibiotic use. If patients failed to achieve the six out of eight 
correct answers, education needs in necessary areas were addressed and clarified with the 
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patients.  The scores of the quiz were not used for analysis purpose but to serve as identifying the 
patients’ education needs and to open dialogue on antibiotics use and URIs between the patients 
and the providers.  
Then, if the patient met the inclusion criteria for the study, the provider discussed the 
project with the patient and asked if the patient was willing to participate. If the patient was 
interested in participating in the study, an informed written consent form (see Appendix F) was 
reviewed with the person and all questions about the study were answered. If the individual 
agreed to participate in the study, he/she was asked to sign the form. The signature was 
witnessed by the provider. One copy of the signed consent form was given to the participant and 
one was kept by the provider. The provider assigned a code to the subject on the consent form 
and documented only the code on an enrollment sheet (see Appendix G) and on the Follow Up 
Response Form (see Appendix H). All documents that identified a subject by name or if a name 
was linked to the code assigned, including the signed consent forms and assigned participant 
numbers were kept in a locked cabinet at the provider’s charting station during the study and 
only the principal investigators and the providers had access to any document that identified the 
participant by name or identification number. Following the completion of the study, all these 
documents were placed in a locked cabinet in the PI’s office. Only the PI had access to this 
cabinet. The records will be kept for three years then shredded. 
Next, provider initiated the “Follow Up Response Form” for the subject and recorded the 
subjects answer to the quiz question, “Do you believe you need antibiotics?” Next, the patients’ 
understanding of the education material presented and the participants’ assigned interventions 
were documented. The first patient enrolled in the study was assigned to Intervention One. The 
next participant was assigned to Intervention Two and so on. Intervention One. The patients 
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who were assigned to Intervention One, or the delayed patient-led prescription strategy, in 
addition to receiving the educational brochure from the CDC What Everyone Should Know and 
Facts about Antibiotics (see Appendix A) and a Symptomatic Prescription (CDC, 2016) [see 
Appendix B], were given the brochure What is Delayed Prescribing? (CDC, 2016) [see 
Appendix C] and a prescription for an antibiotics chosen by the provider based on the subject’s  
history, examination and standard of care for most likely bacterial infection. The prescription 
included instruction to the pharmacy to not fill this prescription 11 days post written date to 
prevent participants filling the antibiotics prescriptions after the study was completed.  While the 
subjects were told they could fill their prescriptions at any time, they were encouraged to wait 
ten days post URI symptoms onset and then only if they were still not feeling better or if the 
symptoms had worsened again after they had been feeling better. Intervention Two. Subjects 
assigned to Intervention Two, or the delayed prescription collection strategy, received the same 
handouts and treatment guidance as the participants in the Intervention One except instead of 
the brochure What is Delayed Prescribing?(CDC, 2016), they received the brochure What is 
Watchful Waiting? (CDC, 2016) [see Appendix D]. Like those in Intervention One, they might 
elect to start antibiotics at any time and were also cautioned to wait ten days post URI symptoms 
onset and then only if they were still not feeling better or if the symptoms worsened again after 
they had been feeling better; but instead of immediately receiving the prescriptions, the 
participants were told to pick up their prescriptions at any time by sending an email, a text  or 
calling the medical assistant at the clinic and identifying themselves by their assigned participant 
number.  When a patient asked for the antibiotics prescription, the medical assistant informed the 
provider of the request and the provider wrote the antibiotics prescription for the patient to pick 
up at the urgent care clinic front desk and to fill the prescription at the hospital pharmacy.          
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  All study participants were directed to fill the antibiotics prescriptions at the hospital 
pharmacy which was usually the least expensive option and because urgent care clinic shares the 
same EHR. This was important because the urgent care providers had direct access to the 
hospital pharmacy records and they could generate a list of patients to monitor if and when they 
filled their prescriptions.  
The number of antibiotics prescriptions filled by the study participants was verified from 
the patients’ pharmacy records which was part of the EHR. The principal investigator assessed 
the study participants’ pharmacy records of the EHR daily to record the filling of antibiotic 
prescriptions. If a participant filled the antibiotics prescription, the number of days between 
receiving the prescription and filling the prescription was documented on the Follow Up 
Response Form (Appendix H) by the provider.  
The MA scheduled a follow-up visit ten days from the day the patient consented to 
participate in the study, free of charge to the participant. Participants were told they could cancel 
or reschedule this visit if not needed or desired. Since this is a walk-in urgent care clinic, 
cancellation or reschedule follow-up appointments of the study participants did not have 
significant impact to the clinic’s productivity. 
Instruments. The CDC’s Get Smart Antibiotics Quiz (CDC, 2016) (Appendix K) 
assessed the knowledge of appropriate antibiotics use and is available from the CDC website at 
https://www.cdc.gov/getsmart/community/about/quiz.html. Although the CDC did not provide 
any statistics for quiz validity, this quiz had been used by the clinic participating in the study for 
the past year. To validate patient perceptions of the quiz, a sample of 20 patients with 
uncomplicated URIs were invited to complete the quiz and a follow-up questionnaire both before 
and after an education session with their provider. The questionnaire asked what the patient 
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thought was the purpose of the quiz and whether or not he/she felt the quiz accurately measured 
his/her knowledge about inappropriate use of antibiotics. Nineteen of the twenty participants 
reported that their score on the quiz were reflective of their knowledge. Efficacy of the education 
program measured patients’ understanding on proper antibiotics use as documented by a) the 
patients’ belief in the need for antibiotics, b) the patients’ perception on education affect their 
decisions to fill the prescriptions for antibiotics. A Chi-Square Test of Association was used to 
assess the association.  
 The Wisconsin Upper Respiratory Symptom Survey 21(WURSS-21) (Appendix L) is a self-
administered questionnaire developed in the United States to evaluate the severity of the 
common cold. Composite reliability coefficients ranged from 0.87 to 0.97, and Cronbach's alpha 
ranged from 0.76 to 0.96 (Barrett et al., 2009). Illness-specific health-related quality-of-life 
(WURSS) correlates closely with physical health. Both versions of WURSS-44 and 21 yielding 
Pearson correlation coefficients of 0.920, 0.925, and 0.937 on Days 2, 3 and 4, respectively. 
These findings are evidence of convergent validity of the WURSS-21 (Barrett et al., 2009). 
Duration and severity of symptoms as documented by WURSS 21 scores.  
The Follow Up Response Form (Appendix H) measured the patient’s understanding of 
appropriate antibiotics use, and symptomatic treatment for uncomplicated URIs. Face validity 
was established by one FNP and two physicians. Effectiveness between intervention one and two 
in decreasing antibiotics use as documented on the follow-up respond form as a) if patients filled 
the antibiotics prescriptions and b) days (post screening) the patients filled the antibiotics 
prescriptions. Belief in the symptomatic treatment as documented on the follow-up respond form 
as yes or no. Patient satisfaction as documented on the Follow-Up Response Form using a zero 
to five points Likert scales ranging from “not at all satisfied” to “very satisfied.” 
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Both physicians and FNP served on the committee of the quality improvement (QI) teams 
of the hospital affiliated with the clinic where the study will take place. The QI team included a 
diverse group of individuals who had different roles and perspectives on the patient care and the 
hospital was currently conducting research on inappropriate antibiotics use supported by The 
Agency for Healthcare Research and Quality (AHRQ).  The QI committee members 
participating in this project are subject matter experts on the research on the research of 
inappropriate antibiotics use. The primary investigator (PI) for the project and the faculty 
directing the project completed CITI training (see Appendix E and Appendix F) and approval 
was obtained for the study from the urgent care clinic’s medical director. IRB approval was 
attained from the Regis University prior to beginning the project. UMCC hospital IRB was not 
required since the study was a QI project and was not being conducted in the premise of the 
hospital. 
Risk Evaluation 
 Potential risks for the participants included fear of not receiving standard of care if they do 
not participate in the project, fear of not answering the quiz currently or having their scores 
influence the level of care, and possible fear of delayed healing from not starting immediate 
antibiotics therapy. Although all the HIPAA guidelines were meticulously followed, there was 
fear of breeches of privacy, or fear of care providers becoming disappointed in them for starting 
the antibiotics and no longer being willing to treat them in the future. There was a risk for 
physical and emotional distress from waiting to start antibiotics, and possible delay treatment; 
however, all the participants were informed that the participation in the project was voluntarily 
and they could revoke consent to participate at any time. All the documentation related to the 
project including subject identification was stored in a locked and secured cabinet of the urgent  
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care clinic and will be shredded and destroyed in three years. Only the PI, office manager and 
care providers had access to this documentation. HIPAA is strictly mandated in the urgent care 
clinic.  
All participants were provided contact information for the PI, project mentor, faculty and 
IRB representatives and told how to contact the urgent care clinic during business hours with 
questions and support. All participants were instructed to schedule follow-up visit if they did not 
feel well or noted new symptoms.  
 The participants were given verbal and written instructions (see Appendix C and D) that 
they could fill and start antibiotics any time after the office visit, regardless of continued 
participation in the project or not. They were also reminded they could drop out of the project at 
any time but did not need to drop out of study if they elected to start the antibiotics immediately. 
No compensations were offered for participation in the study other than the free follow-up 
appointment. 
The collaborating urgent care providers and supporting staff agreed to participate and 
provide the clinic space and equipment for the project without financial compensation from the 
project. The benefits to the participants were the free project related office follow-up visit, the 
additional education on inappropriate antibiotics use and possibly a decrease in adverse effects 
associated from antibiotics from decrease use.  
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Project Findings and Results 
Sample Description 
 From October 11, 2017 to Oct 21, 2017, a total of 108 subjects met the inclusion criteria and 
were invited to participate in the study. Sixty-seven subjects agreed to participate. Fifty of the 
participants provided complete data sets with no missing values. Overall 33 participants (49.3%) 
were male and 34 (50.7%) were female. Fifty-nine (92.2%) of the subjects reported some college 
education (Table 2). Of the 59 participants, an additional 17 (26.6%) stated having an advanced 
degree beyond bachelor’s degree as well. The most common diagnosis was viral pharyngitis 
(n=13; 19.4%), followed by sinusitis (n=12; 17.9%) and URI (n=11, 16.4%). 
 Table 2. 
 Baseline Patient Characteristics 
Characteristics Intervention One 
Patient Led 
(n=33) 
Intervention Two 
Collection 
(n=34) 
Total 
 
(n=67) 
Gender    
Male 19 (28.4%) 14 (20.9%) 33 (49.3%) 
Female 15 (22.4%) 19 (28.4%) 34 (50.7) 
Age    
18-30 14 (20.9%) 10 (14.9%) 24 (35.8%) 
31-40 5 (7.5%) 11 (16.4%) 16 (23.9%) 
41-50 6 (9%) 6 (9%) 12 (17.9%) 
51-60  6 (9%) 2 (3%)  8 (11.9) 
61-65 3 (4.5%) 4 (6%) 7 (10.4%) 
Types of URIs    
Bronchitis 5 (7.5) 3 (4.5)  8 (11.9) 
Pharyngitis 7 (10.4)  6 (9) 13 (19.4) 
Sinusitis 5 (7.5) 7 (10.4) 12 (17.9) 
Cold 5 (7.5) 5 (7.5) 10 (14.9) 
Viral syndrome 2 (3) 3 (4.5) 5 (7.5) 
URI 6 (9)  5 (7.5) 11 (16.4) 
Otalgia 4 (6.0) 4 (6.0)  8 (11.9) 
Educational level    
High School 2 (3.1%) 3 (4.7%) 5 (7.8%) 
Some College 22 (34.4)  20 (31.3) 42 (65.6) 
Advanced Degree 9 (14.1) 8 (12.5) 17 (26.6) 
Not Answered 0  3 (4.7%) 3 (4.7%) 
Severity of symptoms    
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Not sick/very mild 0 0 0 
Mild 4 (6%) 1 (1.5%)  5 (7.5) 
Moderate 17 (25.4) 16 (23.9) 33 (49.3) 
Severe 13 (19.4) 16 (23.9) 29 (43.3) 
Need for antibiotics    
Yes 26 (38.8%) 25 (37.3) 51 (76.1%) 
No 0 3 (4.5%) 3 (4.5%) 
Not sure 8 (11.9%)   5 (7.5%) 13 (19.4%) 
  
Comparison Between Intervention One and Intervention Two 
Overall 34 (50.7%) of the subjects ended up filling the antibiotics prescriptions and 33 
(49.3%) did not fill their antibiotics prescriptions (see Table 3). For subjects who ended up 
filling their prescriptions, 20 (20.9%) of the subjects filled their prescriptions in 1-3 days post 
screening (day zero), and 14 (20.9%) subjects waited till day 4-6 post screening to fill their 
antibiotics prescriptions (see Table 3).  
The Chi-Square Test of Association showed that there was an association between 
antibiotics used and different intervention groups (X2=9.344, p<0.05). In Intervention One--the 
patient led delayed prescription strategy, 23 subjects (34.3%) did not use antibiotics, compared to 
the ten subjects (14.9%) in Intervention Two- the collection delayed prescriptions strategy did 
not fill their antibiotics prescriptions (see Table 4). 
While the subjects in the patient led delayed prescription strategy use antibiotics less than 
those in the collection delayed prescription strategy, it is worthwhile to mention that there was an 
association between the days the subjects filled their prescriptions for antibiotics in different 
intervention groups. Nine subjects (13.4%) from the collection strategy and five subjects (7.1%) 
waited four to six days before using antibiotics.  
 Our study results showed that Intervention One- the patient led delayed prescription 
strategy decreased the antibiotics use more effectively compared to the Intervention Two-
collective delayed prescription strategy. We predicted that the collective strategy would decrease 
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antibiotics use more than the patient led intervention. The hassle of having to call our clinic for a 
prescription would serve as a deterrent. The low use of antibiotics observed in the patient led 
delayed was unexpected. During the follow up visit, several subjects from the patient led strategy 
reported that having the antibiotics prescriptions on hand served as a “safety net”. They were 
willing to try symptomatic treatment longer because of that. 
Table 3 
 Antibiotic Rx Filled and Patient Satisfaction Between Interventions 
Characteristics Intervention One 
Patient Led 
(n=33) 
Intervention Two 
Collection 
(n=34) 
Total 
Antibiotic Rx filled    
Yes 11 (16.4%) 23 (34.3%) 34 (50.7%) 
No 23 (34.3%) 10 (14.9%) 33 (49.3%) 
Days antibiotics 
filled 
   
Not filled 23 (34.3%) 10 (14.9%) 33(49.3%) 
Day 1-3 6 (9%) 14 (20.9%) 20 (20.9%) 
Day 4-6 5 (7.5%) 9 (13.4%) 14 (20.9%) 
Day 7-10 0 0 0 
Patient satisfaction    
Very unsatisfied-
somewhat unsatisfied 
0 0 0 
Somewhat satisfied 3 (4.5%) 12 (17.9%) 15 (22.4%) 
Satisfied 20 (29.9%) 16 (23.9%) 36 (53.7%) 
Very Satisfied 11 (16.4%) 5 (7.5%) 16 (23.9%) 
 
Table 4 
 
Filling of Antibiotic Rx Between Interventions 
 
 
ABx Rx filled 
Total no yes 
Intervention Intervention A Count 23 11 34 
% of Total 34.3% 16.4% 50.7% 
Intervention B Count 10 23 33 
% of Total 14.9% 34.3% 49.3% 
Total Count 33 34 67 
% of Total 49.3% 50.7% 100.0% 
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Statistics 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 9.344a 1 .002  
Continuity Correctionb 7.909 1 .005  
Likelihood Ratio 9.576 1 .002  
Fisher's Exact Test    .003 .002 
Linear-by-Linear 
Association 
9.204 1 .002  
N of Valid Cases 67    
 
 
Education Program Outcomes 
On day 0 (screening day), prior to receiving the educational program and discussion, 51 
(76.1%) subjects stated that antibiotics were needed for their conditions. Thirteen (19.4%) 
subjects were not sure about the need for antibiotics, and three (4.5%) of the subjects stated that 
they did not need antibiotics. After reading the CDC Get Smart About Antibiotics brochure, 
completing the post reading quiz and discussion with the providers, 64 (95.5%) subjects reported 
that antibiotics were not necessary with three (4.5%) subjects stated that they were not sure (see 
Table 5). All the 67 (100%) subjects verbalized understanding of the educational material. Fifty-
eight participants (86.6%) said that the education material affected their decisions on filling the 
antibiotics prescriptions; while, nine (13.4%) stated the education material they received on 
screening day did not affect their decisions on filling the antibiotic prescriptions. There was no 
association between the impact of patient education and antibiotics use (X2=-3.039, p>0.05 Chi-
Square Test) [See Table 6]. 
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Table 5 
 
Perception on Education Program Affecting Decision on Filling Antibiotic Prescriptions 
Characteristics Intervention One 
Patient Led 
(n=33) 
Intervention Two 
Collection 
(n=34) 
Total 
 
(n=67) 
Perceived need for 
antibiotic before 
education 
   
Yes 26 (38.8%) 25 (37.3%) 51 (76.1%) 
No 0 (0%) 3 (4.5%) 3 (4.5%) 
Not sure 8 (11.9%) 5 (7.5%) 13 (19.4%) 
Perceived need for 
antibiotics after 
education 
   
Yes 0 (0%) 0 (0%) 0 (0%) 
No 32 (47.8%) 32 (47.8) 64 (95.5%) 
Not sure 2 (3%) 1 (1.5%) 3 (4.5%) 
Patients’ Perception 
on the education 
materials affecting 
decision on filling 
antibiotic 
prescriptions 
   
Yes 30 (44.8%) 28 (41.8%) 58 (86.6%) 
No 4 (6%) 5 (7.5%) 9 (13.4%) 
Patients filled 
antibiotics 
   
Yes 11 (16.4%) 23 (34.3%) 34 (50.7%) 
No 23 (34.3%) 10 (14.9%) 33 (49.3%)  
 
Table 6 
Rx Filled and Education’s Effect on Decision  
 
Ed Material affect ABx Rx 
decision 
Total yes No 
ABx Rx 
filled 
no Count 31 2 33 
% of Total 46.3% 3.0% 49.3% 
yes Count 27 7 34 
% of Total 40.3% 10.4% 50.7% 
Total Count 58 9 67 
% of Total 86.6% 13.4% 100.0% 
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Statistics 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 3.039a 1 .081   
Continuity Correctionb 1.918 1 .166   
Likelihood Ratio 3.203 1 .073   
Fisher's Exact Test    .150 .082 
Linear-by-Linear 
Association 
2.994 1 .084   
N of Valid Cases 67     
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is 4.43. 
b.  
Impact of Education on Patient Satisfaction 
There was an increase in patient’s satisfaction to the treatment they received for those 
that said the education material affected their decisions on antibiotics use (X2=12.392, p<0.01) 
[see Table 7], regardless of the intervention group they were assigned (X2=0.165, p>0.05); but, 
the subjects’ perceptions on the need for antibiotics before (X2=2.418, p>0.05) and after 
(X2=3.048, p>0.05) the education were not associated with antibiotics use.  
Our study indicated that while the subjects reported that the education material influenced their 
decision to fill the antibiotic prescriptions, the statistical analysis showed a different pattern. The 
educational material did not make any impact in actual antibiotic used in the subjects with 
uncomplicated URIs. However, the patient satisfaction revealed that the subjects appreciated 
additional time spent with the providers and knowledge gained on their conditions. This 
suggestion could not be verified by the study.   
 Chi-Square Test of Association (see Table 6) showed that there were no association between 
the impact of patient education and antibiotics use (X2=-3.039, p>0.05), however, there was a 
difference with the patient’s satisfaction and those who felt that the education material affects 
their decisions on antibiotics use (Z=-3.198, p<0.01). In addition to that, there were no 
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association between the impact of patient education and different intervention groups (X2=0.165, 
p>0.05). The Chi-Square Test of Association also illustrated that the subjects’ perceptions on the 
need for antibiotics before (X2=2.418, p>0.05) and after (X2=3.048, p>0.05) education were not 
associated with antibiotics use at the end of study. 
 A total of 67 participants were recruited for this project. Before education session, 51 of the 
67 subjects said that they needed antibiotics for their conditions. At the end of the study, 34 of 
the subjects ended up using antibiotics. There was a 25% reduction in antibiotics use. The 
educational program did not make any statistically significant in decreasing the use of 
antibiotics. All the study participants verbalized understanding of the education material. Most 
subjects (n=51, 76.1%) who started with stating they wanted antibiotics prior to the education, 
verbalized that antibiotics might not be necessary after the education. Fifty-eight of the 67 
(86.6%) of the participants felt that the education would impact their decision on antibiotics use, 
but statistical analysis showed that there were no association between the impact of patient 
education and antibiotics use (X2=-3.039, p>0.05) [See Table 6]. 
Table 7 
Patient’s Satisfaction and Education  
Pt Satisfaction * Ed Material affect ABx Rx decision Crosstabulation 
 
Ed Material effect ABx Rx 
decision 
Total yes No 
Pt Satisfaction Somewhat Satisfied Count 9 6 15 
% of Total 13.4% 9.0% 22.4% 
Satisfied Count 33 3 36 
% of Total 49.3% 4.5% 53.7% 
Very Satisfied Count 16 0 16 
% of Total 23.9% 0.0% 23.9% 
Total Count 58 9 67 
% of Total 86.6% 13.4% 100.0% 
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 Value df 
Asymptotic 
Significance (2-
sided) 
Pearson Chi-Square 12.392a 2 .002 
Likelihood Ratio 12.025 2 .002 
Linear-by-Linear Association 10.288 1 .001 
N of Valid Cases 67   
a. 3 cells (50.0%) have expected count less than 5. The minimum 
expected count is 2.01. 
 
Symptomatic Treatment 
In general, 36 (53.7%) subjects felt that symptomatic treatment was helpful, 14 (20.9%) 
of the subjects did not think it help, and 17 (25.4%) subjects were not sure if symptomatic 
treatment helped (see Table 8). Twenty-five subjects (37.7%) who perceived symptomatic 
treatment as helpful ended up not using antibiotics. There is an association between antibiotics 
used and the patient’s perception on the helpfulness of symptomatic treatment (X2=13.693, p ≤ 
0.001). The subjects who were unsure or felt that symptomatic treatment was not helping 34 
subjects (23%) filled their antibiotics prescriptions during the study. Seven (10.4%) of the 
subjects who believed that symptomatic treatment was helpful waited longer to fill their 
antibiotic prescriptions compared to those who felt unsure or that the symptomatic treatment was 
not helpful (see Table 9). There was an association between days subjects waited to fill their 
antibiotics prescriptions and the patient’s perception on the helpfulness of symptomatic treatment 
(X2=15.360, p ≤ 0.001). 
More than half of the subjects stating that symptomatic treatment helped, and 
symptomatic treatment was included in the educational program, the perceived helpfulness of 
symptomatic treatment was strongly associated with decreased antibiotics use in this study. The 
perception of helpfulness of the symptomatic treatment seemed to encourage the subjects to try 
the treatment longer and hold off filling their antibiotic prescriptions.  
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Table 8 
 
 Symptomatic treatment and Filling Antibiotic Rx  
 
 
Helpfulness of Sym Tx 
Total no yes Not Sure 
ABx Rx 
filled 
no Count 5 25 3 33 
% of Total 7.5% 37.3% 4.5% 49.3% 
yes Count 9 11 14 34 
% of Total 13.4% 16.4% 20.9% 50.7% 
Total Count 14 36 17 67 
% of Total 20.9% 53.7% 25.4% 100.0% 
 
Statistics 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 13.693a 2 .001 
Likelihood Ratio 14.458 2 .001 
Linear-by-Linear 
Association 
1.544 1 .214 
N of Valid Cases 67  
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Table 9 
 
Perceived Helpfulness of Antibiotics and Day Prescriptions Filled   
 
 
Helpfulness of Sym Tx 
Total no yes Not Sure 
Day ABx Rx 
Filled 
Not filled Count 5 25 3 33 
% of Total 7.5% 37.3% 4.5% 49.3% 
Day 1-3 Count 7 4 9 20 
% of Total 10.4% 6.0% 13.4% 29.9% 
Day 4-6 Count 2 7 5 14 
% of Total 3.0% 10.4% 7.5% 20.9% 
Total Count 14 36 17 67 
% of Total 20.9% 53.7% 25.4% 100.0% 
      
 
Statistics 
 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 15.360a 2 .000 
Likelihood Ratio 16.233 2 .000 
Linear-by-Linear 
Association 
1.584 1 .208 
N of Valid Cases 67  
a. 0 cells (0.0%) have expected count less than 5. The 
minimum expected count is 6.90. 
 
Duration and Severity of Symptoms 
The median of severity of symptoms on day zero or day of screening was rated as three 
or moderate (81-120 on WURSS 21) with zero corresponding to not sick and four as severe (see 
Table 10). Thirty-three (49.3%) of the subjects complained of moderate severity symptoms upon 
first visit, and 29 (43.3%) rated their symptoms as severe. The presence of symptoms at the day 
of screening or first visit was similar among the two intervention groups (p>0.05). Overall 62 
(92.6%) of the subjects were experiencing moderate to severe symptoms.  
On day three (see Table 11), 29 (43.3%) of the patient reported moderate symptoms severity, 26 
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(38.8%) rated their symptoms as severe.  Of all the 26 participants who rated their symptoms as 
severe, 18 (69.2%) of those were subjects assigned to Intervention B. Twelve (17.9%) subjects 
rated their symptoms as mild at day three compared to only five (7.5%) reported of mild 
symptoms on day zero. On day seven (see Table 12), no participants rated their symptoms as 
severe. Only five (7.5%) participants rated their symptoms as moderate. 46 (68.6%) of the 
participants rated their symptoms as very mild to mild. thirteen (19.4%) of the subjects reported 
of not sick. On day ten, (see Table 13) fifty-two (77.6%) of the subjects reported of not sick, 
seven (10.4%) with very mild symptoms, no participants reported of moderate or worse 
symptoms and eight subjects did not return their day 10 survey. 
Table 10 
 
Severity of Symptoms on Day Zero Between Intervention Groups  
 
 
Intervention 
Total Intervention A Intervention B 
WURSS 21 D0 Mild (41-80) Count 4 1 5 
% of Total 6.0% 1.5% 7.5% 
Moderate (81-120) Count 17 16 33 
% of Total 25.4% 23.9% 49.3% 
Severe (>120) Count 13 16 29 
% of Total 19.4% 23.9% 43.3% 
Total Count 34 33 67 
% of Total 50.7% 49.3% 100.0% 
 
Table 11 
 
Severity of Symptoms on Day Three Between Intervention Groups  
 
 
Intervention 
Total Intervention A Intervention B 
WURSS 21 D3 Mild (41-80) Count 9 3 12 
% of Total 13.4% 4.5% 17.9% 
Moderate (81-120) Count 17 12 29 
% of Total 25.4% 17.9% 43.3% 
Severe (>120) Count 8 18 26 
% of Total 11.9% 26.9% 38.8% 
Total Count 34 33 67 
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% of Total 50.7% 49.3% 100.0% 
      
 
Table 12 
 
Severity of Symptoms on Day Seven Between Intervention Groups 
 
Intervention 
Total Intervention A Intervention B 
WURSS 21 D7 Not sick (0) Count 9 4 13 
% of Total 13.4% 6.0% 19.4% 
Very Mild (1-40) Count 8 17 25 
% of Total 11.9% 25.4% 37.3% 
Mild (41-80) Count 15 6 21 
% of Total 22.4% 9.0% 31.3% 
Moderate (81-120) Count 1 4 5 
% of Total 1.5% 6.0% 7.5% 
not answer Count 1 2 3 
% of Total 1.5% 3.0% 4.5% 
Total Count 34 33 67 
% of Total 50.7% 49.3% 100.0% 
 
 
Table 13 
 
Severity of Symptoms on Day Ten Between Intervention Groups  
 
 
Intervention 
Total Intervention A Intervention B 
WURSS 21 D10 Not Sick (0) Count 27 25 52 
% of Total 40.3% 37.3% 77.6% 
Very Mild(1-40) Count 3 4 7 
% of Total 4.5% 6.0% 10.4% 
not answer Count 4 4 8 
% of Total 6.0% 6.0% 11.9% 
Total Count 34 33 67 
% of Total 50.7% 49.3% 100.0% 
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Table 14  
 
Difference with Antibiotics Used and The Severity of Symptoms 
 
Ranks 
 Intervention N Mean Rank Sum of Ranks 
WURSS 21 D0 Intervention A 34 31.62 1075.00 
Intervention B 33 36.45 1203.00 
Total 67   
WURSS 21 D3 Intervention A 34 28.04 953.50 
Intervention B 33 40.14 1324.50 
Total 67   
WURSS 21 D7 Intervention A 34 33.35 1134.00 
Intervention B 33 34.67 1144.00 
Total 67   
WURSS 21 D10 Intervention A 34 33.46 1137.50 
Intervention B 33 34.56 1140.50 
Total 67   
ABx Rx filled Intervention A 34 27.84 946.50 
Intervention B 33 40.35 1331.50 
Total 67   
Day ABx Rx 
Filled 
Intervention A 34 28.07 954.50 
Intervention B 33 40.11 1323.50 
Total 67   
The Mann-Whitney U analysis (see Table 14) indicated that there was a difference with 
antibiotics used and the severity of symptoms (Z=-3.034, p=0.002).  More specifically, there was 
a difference with antibiotics used and the severity of symptoms on day three (z =-2.747, p =.006) 
while there were no difference with antibiotics used and the severity of symptoms on day zero 
(Z=--1.136, p>0.05); day seven (Z=-0.289, p>0.05) or day ten (Z=-0.319, p>0.05).  The study 
 
 
Statistics 
 
 
WURSS 21 
D0 
WURSS 21 
D3 
WURSS 21 
D7 
WURSS 21 
D10 
ABx Rx 
filled 
Day ABx 
Rx Filled 
Mann-Whitney U 480.000 358.500 539.000 542.500 351.500 359.500 
Wilcoxon W 1075.000 953.500 1134.000 1137.500 946.500 954.500 
Z -1.136 -2.747 -.289 -.319 -3.034 -2.749 
Asymp. Sig. (2-
tailed) 
.256 .006 .772 .750 .002 .006 
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showed that most subjects reported experiencing moderate to severe symptoms when they came 
to the clinic for evaluation. The severity of symptoms gradually decreased after day three, the 
majority of the participants were feeling better by day seven and closed to 80% reported no 
symptoms on day ten. Our study showed that the subjects’ antibiotics used was strongly related 
to the severity of symptoms on day three. 
Patient Satisfaction 
All 67 (100%) subjects expressed favorable views of the treatment and rated at least 3 or 
somewhat satisfied on a 0-5 Likert scale. 15 (22.4%) rated somewhat satisfied, 36 (53.7 %) rated 
4 or satisfied, 16 (23.9%) subjects rated “very satisfied” (see Table 15). 
A Mann-Whitney U test (Table 16) indicated that there was a difference (Z= -2.666, 
P=0.008) with the patient led delayed prescription strategy ranked higher in the patient 
satisfaction than the collection delayed prescriptions. Thirty-one subjects (46.3%) of the 
participants in the patient led delayed prescription were satisfied and very satisfied with the 
treatment compared to the collection delayed prescriptions, 21 subjects (31.4%) were satisfied 
and very satisfied with the treatment. Fifty-three (79.1%) of the subjects stated that they did not 
seek help from another clinics or providers with seven (10%) subjects stated that they did seek 
help at other places. Seven subjects (10.4%) did not return their survey or return for day 10 
complementary office visit. Overall, 67 (100%) of the participants rated their treatment from 
somewhat satisfactory to very satisfied. There was no rating below somewhat satisfactory. In 
addition to the high patient satisfaction, the clinic retained 79% of the subjects. 36 (53.7 %) rated 
4 or satisfied, 16 (23.9%) subjects rated “very satisfied”. 
 
 
TWO DELAYED ANTIBIOTIC PRESCRIPTION STRATEGIES 
43 
 
Table 15  
Patient Satisfaction Between Interventions 
 
 
Pt Satisfaction 
Total 
Somewhat 
Satisfied Satisfied Very Satisfied 
Intervention Intervention A Count 3 20 11 34 
% of Total 4.5% 29.9% 16.4% 50.7% 
Intervention B Count 12 16 5 33 
% of Total 17.9% 23.9% 7.5% 49.3% 
Total Count 15 36 16 67 
% of Total 22.4% 53.7% 23.9% 100.0% 
 
Table 16 
 
Ranking of Patient Satisfaction Between Interventions 
Ranks 
 Intervention N Mean Rank Sum of Ranks 
Pt Satisfaction Intervention 
A 
34 39.66 1348.50 
Intervention B 33 28.17 929.50 
Total 67   
 
Statistics 
 Pt Satisfaction 
Mann-Whitney U 368.500 
Wilcoxon W 929.500 
Z -2.666 
Asymp. Sig. (2-
tailed) 
.008 
a. Grouping Variable: Intervention 
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Limitation, Recommendations, Implications for Practice 
Limitations 
 One limitation to the study was how broadly URIs were defined so that the patient groups 
were comprised of subjects with a wide range of respiratory infections. This resulted in a 
heterogeneous sample which increased variance, making type II error more likely. The subjects 
were not randomized between the two delayed prescription strategies; although the two groups 
were well balanced for the patient characteristics, diagnoses, and severity of symptoms. While 
the study investigated and encouraged symptomatic treatment, complications associated with 
delayed prescription strategies or treatment failures were not assessed.  
Recommendations  
 More research needs to be done to identify if educational programs and patient support in 
combination with the delayed prescription strategies would further reduce the inappropriate use 
of antibiotics. Although there is compelling evidence regarding the benefits of the delayed 
prescription strategies and patient education, additional investigation needs to be conducted on 
possible increased complications associated with delayed prescription strategies. Finally, 
continued study with a larger sample size, more homogenous groups and that includes a no 
prescription group with subjects from different ethnic groups is also recommended.  
Implications for Practice 
The results of the study suggested encouraging patients with a URI the subjects to try 
symptomatic treatment for at least three days prior to filling the antibiotics prescriptions could be 
a successful strategy for decreasing inappropriate antibiotic use.  The results of this project 
illustrated that the delayed prescription strategy was associated with a high level of patient 
satisfaction along with decrease inappropriate antibiotics use.  
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Summary 
At the beginning of the study, prior to the education session with the providers, fifty-one 
(76.1%) of the sixty-seven subjects felt that antibiotics were necessary for their condition. At the 
conclusion of the study, thirty-four (50.7%) of the sixty-seven subjects ended up using 
antibiotics (see Table 4). Assuming all fifty-one of the subjects planned to use antibiotics if the 
prescriptions were given to them, the delay prescription strategies had decreased the utilization 
of antibiotic by 25.4% while maintaining good patient satisfaction. This finding is consistent 
with the systemic reviews that delayed antibiotic prescriptions are associated with decreased 
antibiotic use in uncomplicated URIs (Agnew et al., 2013; De la Poza et al., 2016; Little et al., 
2014).  While the education program seemed like a success to educate subjects on inappropriate 
antibiotics use and the subjects even felt that the education program influenced their decision on 
antibiotic use, the results showed differently. The severity of the symptom on day three post 
office visit seemed to be the major determinant of antibiotic use in subjects. The education 
program failed to show any statistically significant direct impact on decreasing antibiotic use. 
However, the symptomatic treatment, which was part of the educational program, was strongly 
associated with decreased filling of antibiotic prescriptions. Also, the educational program 
contributed to patient satisfaction. The collection group reported a 17.9% higher rate of filling 
antibiotic prescriptions than the patient led group. This was a surprised finding since most 
studies (De la Poza et al., 2016; Little et al., 2014; Sargent, McCullough, Del Mar, & Lowe, 
2016) suggested that subjects assigned to the collection strategies had lower use of antibiotics 
than the patient led strategy presumably due to the hurdle of having to return to the clinic for the 
prescription. Our study showed that subjects seemed to be willing to wait and try the 
symptomatic treatment longer when they have the antibiotic prescriptions on hand.  
TWO DELAYED ANTIBIOTIC PRESCRIPTION STRATEGIES 
46 
 
References 
Albeldawi, M., Aggarwal, A., Madhwal, S., Cywinski, J., Lopez, R., Eghtesad, B. & Zein, N.N. 
(2012). Cumulative risk of cardiovascular events after orthotopic liver transplantation. 
Liver Transplantation 18, 370-375. 
Aqel, B.A. (2009). Should transplant hepatologists serve as primary care physicians? Liver 
Transplantation 15, 1162-1163. 
Banares, R. & Salcedo, M. (2014). Long-term management after liver transplantation: Primary 
care physician versus transplant hospital. Transplantation Proceedings 46, 3095-3096. 
Beste, L.A., Harp, B.K., Blais, R.K., Evans, G.A. & Zickmund, S.L. (2015). Primary care 
providers report challenges to cirrhosis management and specialty care coordination. 
Digestive Diseases and Sciences 60, 2628-2635. 
Cimino, F.M. & Snyder, K.A.M. (2016). Primary care of the solid organ transplant recipient. 
American Family Physician 93(3), 203-210. 
Curry, L.A., Nembhard, I.M., & Bradley, E.H. (2009). Qualitative and mixed methods provide 
unique contributions to outcomes research. Circulation 119: 1442-1452. 
Easley, J., Miedema, B., O’Brien, M.A., Carroll, J., Manca, D., Webster, F. & Grunfeld, E. 
(2017). The role of family physicians in cancer care: perspectives of primary and 
specialty care providers. Current Oncology 24(2), 75-80. 
Galindo, R.J., Fried, M., Breen, T., & Tamler, R. (2016). Hyperglycemia management in patients 
with posttransplantation diabetes. Endocrine Practice 22(4), 454-465. 
Heller, J.C., Prochazka, A.V., Everson, G.T., & Forman, L.M. (2009). Long-term management 
after liver transplantation: Primary care physicians versus hepatologist. Liver 
Transplantation 15(10), 1330-1335. 
TWO DELAYED ANTIBIOTIC PRESCRIPTION STRATEGIES 
47 
 
Hughes, L.D. (2014). The transplant patient and transplant medicine in family practice. Journal 
of Family Medicine and Primary Care 3(4), 345-354. 
Kahn, A., Reynolds, J.A., Chakkera, H.A., Aqel, B.A., Byrne, T.J., Douglas, D.D., . . . Carey, 
E.J. (2016).  Prospective analysis of metabolic parameters in the detection of diabetes and 
metabolic syndrome in liver transplant recipients. Metabolic Syndrome and Related 
Disorders 14(6), 305-310. 
Kim, B., Lucatorto, M.A., Hawthorne, K., Hersh, J., Myers, R., Elwy, A.R. & Graham, G.D. 
(2015). Care coordination between specialty care and primary care: A focus group study 
of provider perspectives on strong practices and improvement opportunities. Journal of 
Multidisciplinary Healthcare 8, 47-58. 
Loeb, D.F., Binswanger, I.A., Candrian, C., & Bayliss, E.A. (2015). Primary care physician 
insights into a typology of the complex patient in primary care. Annals of Family 
Medicine 13(5), 451-455. 
Lucey, M.R., Terrault, N., Ojo, L., Hay, E., Neuberger, J., Blumberg, E., & Teperman, L.W. 
(2013). Long-term management of the successful adult liver transplant: 2012 Practice 
guidelines by the American association for the study of liver diseases and the American 
society of transplantation. Liver Transplantation 19(3), 3-26. 
Mandl, K.D., Olson, K.L., Mines, D., Liu, C., & Tian, F. (2014). Provider collaboration: 
cohesion, constellations, and shared patients. Journal of General Internal Medicine 
29(11), 1499-1505. 
McCashland, T.M. (2001). Posttransplantation care: Role of primary care physician versus 
transplant center. Liver Transplantation 7(11), S2-S12. 
TWO DELAYED ANTIBIOTIC PRESCRIPTION STRATEGIES 
48 
 
McGuire, B.M., Rosenthal, P., Brown, C.C., Busch, A.M.H., Calcatera, S.M., Claria, R.S., … 
Sudan, D.L. (2009). Long-term management of the liver transplant patient: 
Recommendations for the primary care doctor. American Journal of Transplantation 9, 
1988-2003. 
Mishel, M.H. (1988). Uncertainty in illness. Journal of Nursing Scholarship, 20(4), 225-231. 
O’Malley, A.S. and Reschovsky, J.D. (2011). Referral and consultation communication between 
primary care and specialist physicians. Archives of Internal Medicine 171(1), 56-65. 
Parekh, J., Corley, D.A., and Feng, S. (2012). Diabetes, hypertension and hyperlipidemia: 
Prevalence over time and impact on long-term survival after liver transplantation. 
American Journal of Transplantation 12, 2181-2187. 
Reeves, S., Pelone, F., Harrison, R.,  Goldman, J., and Zwarenstein, M. (2017). Interprofessional 
collaboration to improve professional practice and healthcare outcomes. Cochrane 
Collaboration. DOI:10.1002/14651858.CD000072.pub2 
Said, A., Gagovic, V., Malecki, K., Givens, M.L., & Nieto, F.J. (2013). Primary care 
practitioners survey of non-alcoholic fatty liver disease. Annals of Hepatology 12(5), 
758-765. 
Terry, A.J. (2015). Clinical research for the doctor of nursing practice (2nd ed.) Burlington, 
MA: Jones and Bartlett Learning. 
Therasse, A., Wallia, A., & Molitch, M.E. (2013). Management of post-transplant diabetes. 
Current Diabetes Reports 13, 121-129. 
Tuckman, B.W. (1965). Developmental sequence in small groups. Psychological Bulletin, 63(6), 
384-399.  
TWO DELAYED ANTIBIOTIC PRESCRIPTION STRATEGIES 
49 
 
Tuckman, B.W. & Jensen, M.C. (1977). Stages of small-group development revisited. Group & 
Organization Studies 2(4), 419-427. 
Weiss, D., Tilin, F., Morgan, M. (2018). The Interprofessional health care team: Leadership and 
development. Burlington, MA: Jones & Bartlett. 
Wong, C.J. & Pagalilauan, G. (2015). Primary care of the solid organ transplant recipient. 
Medical Clinics of North America 99, 1075-1103. 
Younossi, Z.M., Stepanova, M., Saab, S., Kalwaney, S., Clement, S., Henry, L., Frost, S. & 
Hunt, S. (2014). The impact of type 2 diabetes and obesity on the long-term outcomes of 
more than 85000 liver transplant recipients in the US. Alimentary Pharmacology and 
Therapeutics, 40, 686-694. 
Yu, C.H., Stacey, D., Sale, J., Hall, S., Kaplan, D.M., Ivers, N., Rezmovitz, J., Leung, F., Shah, 
B.R., & Straus, S.E. (2014).  Designing and evaluating an interprofessional shared 
decision-making and goal-setting decision aid for patients with diabetes in clinical care - 
systematic decision aid development and study protocol. Implementation Science 9 (16), 
1-8.  
Zuchowski, J.L., Rose, D.E., Hamilton, A.B., Stockdale, S.E., Meredith, L.S., Yano, E.M., 
Rubenstein, L.V., & Cordasco, K.M. (2015). Challenges in Referral Communication 
Between VHA Primary Care and Specialty Care. Journal of General Internal Medicine 
30(3), 305-311. 
 
TWO DELAYED ANTIBIOTIC PRESCRIPTION STRATEGIES 
50 
 
Appendix A 
What Everyone Should Know and Facts about Antibiotics 
Antibiotics resistance is a growing problem, both in the United States and across the world. The 
main driving factors behind antibiotics resistance are the overuse and misuse of antibiotics. Learn 
more below about when antibiotics are and are not needed for common infections, and the potential 
harms of using antibiotics. 
If You Have a Cold or Flu, Antibiotics Won’t Work for You 
Are you aware that colds, flu, most sore throats, bronchitis, and many sinus and ear infections are 
caused by viruses? Did you know that antibiotics do not help fight viruses? It’s true. For the 
overwhelming majority of common respiratory infections, antibiotics are not helpful. 
Get Smart…Read the Chart! To know which common illnesses are usually viral or bacterial and 
when antibiotics are necessary. 
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What Everyone Should Know and Facts about Antibiotics 
Antibiotics cure bacterial infections, not viral infections such as: Colds or flu, most coughs and 
bronchitis, most sore throats, runny noses 
Taking antibiotics for viral infections will not: Cure the infection, keep other individuals from 
catching the illness, and help you feel better 
Antibiotics Can Cause More Harm than Good 
Taking antibiotics when you have a virus may do more harm than good: 
 
• Taking antibiotics increases your risk of getting an antibiotics-resistant infection later. 
• Antibiotics kill the healthy bacteria in the gut, allowing more harmful bacteria, such as C. difficile, 
to grow in its place. 
o Although this infection is more commonly found in hospitals, it also occurs in clinics outside 
of the hospital.  
• Antibiotics cause 1 out of 5 emergency department visits for adverse drug events. 
o Antibiotics are the most common cause of emergency department visits for adverse drug 
events in children under 18 years of age. 
It’s important to only take antibiotics for bacterial infections since they can put you or your child at 
risk for harmful side effects and antibiotics-resistant infections. 
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What Everyone Should Know and Facts about Antibiotics 
Facts about Antibiotics Resistance 
• Antibiotics resistance is one of the world’s most pressing public health problems. 
• Every time a person takes antibiotics, sensitive bacteria are killed, but resistant ones may be left 
to grow and multiply. 
• Overuse of antibiotics is a major modifiable cause of increases in drug-resistant bacteria. 
• Overuse and misuse of antibiotics threatens the usefulness of these important drugs. 
Decreasing inappropriate antibiotics use is a key strategy to control antibiotics resistance. 
• Antibiotics resistance in children and older adults are of particular concern because these age 
groups have the highest rates of antibiotics use. 
• Antibiotics resistance can cause significant suffering for people who have common infections 
that once were easily treatable with antibiotics. 
• When antibiotics do not work, infections often last longer, cause more severe illness, require 
more doctor visits or longer hospital stays, and involve more expensive and toxic medications. 
Some resistant infections can even cause death. 
Antibiotics Prescribing: Attitudes, Behaviors, Trends and Cost 
• At least 30% of antibiotics courses prescribed in the outpatient setting are unnecessary, 
meaning that no antibiotics is needed at all. Most of this unnecessary use is for acute respiratory 
conditions, such as colds, bronchitis, sore throats caused by viruses, and even some sinus and 
ear infections  
• Total inappropriate antibiotics use (which includes unnecessary antibiotics use plus 
inappropriate antibiotics selection, dosing, and duration) may approach 50% of all outpatient 
antibiotics use  
• The number of antibiotics prescriptions written for children has decreased in recent years    
• Antibiotics cause 1 out of 5 emergency department visits for adverse drug 
events (ADEs). Antibiotics are the most frequent cause of ADEs leading to emergency 
department visits in children, and 7 of the top 10 drugs involved in ADEs leading to 
emergency room visits are antibiotics   
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    Appendix B 
Symptomatic Prescription Rx  
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Appendix C 
Delay Antibiotics Prescription 
 
 
**You may fill the antibiotic prescription that you received on screening day at 
ANYTIME in the next 10 days at the UMCC hospital pharmacy**  
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Appendix D 
Patient Collection Strategy 
 
 
** Please call our medical assistant Takeem or Tabitha at 301-609-4699 ANYTIME in the next 
ten days should you decide on collecting your antibiotic prescription at the urgent care 
clinic and fill your antibiotic prescription at the UMCC hospital pharmacy** 
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Appendix E 
CITI Training Certificate 
 
COLLABORATIVE INSTITUTIONAL TRAINING INITIATIVE (CITI PROGRAM) 
COURSEWORK REQUIREMENTS REPORT* 
 
* NOTE: Scores on this Requirements Report reflect quiz completions at the time all 
requirements for the course were met. See list below for details. 
See separate Transcript Report for more recent quiz scores, including those on optional 
(supplemental) course elements. 
 
• Name: Foong-Chee Cheah (ID: 5384142) 
• Email: fcheah@regis.edu 
• Institution Affiliation: Regis University (ID: 745) 
• Institution Unit: Nursing 
• Curriculum Group: Human Research 
• Course Learner Group: Social Behavioral Research Investigators and Key Personnel 
• Stage: Stage 1 - Basic Course 
• Report ID: 18667089 
• Completion Date: 02/09/2016 
• Expiration Date: 02/08/2019 
• Minimum Passing: 80 
• Reported Score*: 93 
 
REQUIRED AND ELECTIVE MODULES ONLY DATE COMPLETED 
Belmont Report and CITI Course Introduction (ID: 1127) 02/09/16 
History and Ethical Principles - SBE (ID: 490) 02/09/16 
The Federal Regulations - SBE (ID: 502) 02/09/16 
Assessing Risk - SBE (ID: 503) 02/09/16 
Informed ENROLLMENT - SBE (ID: 504) 02/09/16 
Privacy and Confidentiality - SBE (ID: 505) 02/09/16 
Regis University (ID: 1164) 02/09/16 
For this Report to be valid, the learner identified above must have had a valid affiliation with the 
CITI Program subscribing institution 
identified above or have been a paid Independent Learner. 
CITI Program 
Email: citisupport@miami.edu 
Phone: 305-243-7970 
Web: https://www.citiprogram.org 
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CITI Training Certificate 
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Appendix F 
 
Informed Consent 
 
 Title of Study: The Difference in Antibiotics Prescriptions Filled between Patients Receiving 
the Delayed Patient-led Prescription Strategy and Those Receiving Delayed Prescription 
Collection Strategy for Uncomplicated Upper Respiratory Infections 
 
Principal Investigator:  
Name  : Foong-Chee Joann Cheah FNP-BC 
Department  : UMCC Urgent care clinic 
Address : 500 Charles St., La Plata MD 20646 
Phone   : 301-609-4699 
E-mail  : fcheah@regis.edu 
 
 
 Background:  
You are being invited to take part in a research study. Before you decide to participate in this 
study, it is important that you understand why the research is being done and what it will 
involve. Please take the time to read the following information carefully. Please ask the 
researcher or anyone listed below under contact information any questions you have about the 
study or if you would like to know more about the study.   
 
The purpose of this research is to compare and study two different delayed antibiotics strategies 
and patient satisfaction with a treatment plan designed to appropriately care for adult subjects 
with an uncomplicated upper respiratory infection such as colds, influenza, sore throat, 
bronchitis, cough or nasal congestion at the University of Maryland Charles Regional Medical 
Center (UMCC) Urgent Care Clinic in Charles County, Maryland.  
 
Your expected time commitment for this study is approximately 45-75 minutes over the next ten 
days.  
• 10-15 minutes today to learn about the study and consider participation,  
• 10-15 minutes to reply to an email and complete a 21 question survey three days from today 
• 10-15 minutes to reply to an email and complete a 21 question survey again seven days from 
today 
• 15-30 minutes follow-up visit ten days from will be scheduled for you. There will not be any 
charges to you for the follow-up visit.  
TWO DELAYED ANTIBIOTIC PRESCRIPTION STRATEGIES 
59 
 
 
Study Procedure:  
We are inviting all adult subjects who come to this urgent care clinic for treatment of symptoms 
of cough, earache, nasal congestion, sinus problems, or sore throat to participate in this study. 
Whether you decide to participate in our study or not, you will receive the exact same evaluation 
and treatment plan with two exceptions. The first is how you receive a prescription for an 
antibiotics if it is determined that you do not need the antibiotics at this time. The second 
difference is if you participate you will be offered a free follow-up appointment ten days from 
now to discuss your experience of being part of the study and in part to assure you have 
recovered from your illness. You may elect to cancel the follow-up visit or to stop participation 
in the study at any time even if you signed the consent form previously.  
 
If you decide to participate in this study, you will be assigned to one of the two possible ways for 
you to receive antibiotics if they are needed.  Both plans give you access to antibiotics 
immediately if you need them but each in a slightly different way. The researcher will compare 
the two methods to see which method is more satisfying for the subjects and which method is 
better at encouraging using antibiotics appropriately. Both strategies include a prescription for 
antibiotics, and regardless of which strategy is assigned to you, you are encouraged to only fill 
the prescription for the antibiotics if you are not feeling better after ten days of feeling sick or if 
you feel worse after starting to feel better in three or more days from now.  
 
If you participate, I ask that you fill out a 21 question questionnaire about your symptoms today, 
again in three days and one last time in seven days (a total of three questionnaires). These 
questionnaires take about 10-15 minutes each to answer. The first one you will complete now 
and return to me. You can return the day three and day seven questionnaires to me in any of 
following ways, whichever one is easiest for you.  
 
By email: If you provide me with the email address you would like me to use, I will send you a 
link for the online version of the survey with a reminder to please fill it out on day three and 
again a reminder to fill it out on day seven.     
 
      By hand: If you prefer to fill the questionnaires out by hand, two copies of questionnaires will be 
given to you today with the date on top to fill of when to complete it (one three days from now 
and another one seven days from now). You may return both questionnaires to the provider in 
person during your free office visit or mail them to me if you elect not to return for your follow-
up visit. Please ask me for the return postage paid envelopes if this is the method you prefer for 
returning the questionnaires.  
 
You will receive an email from the clinic in three days and again in seven days to check on how 
you are doing, answer questions that you may have and to remind you to complete the survey 
again.  
 
Risks for Participation in the Study: 
The risks to you of participating in the study are minimal. There is the additional time 
commitment on your part to complete the surveys but you will have the same access to 
antibiotics if you participate or elect not to participate in the study. The only difference is the 
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way you would get your antibiotics prescription. If this causes you any stress, you may choose to 
withdraw from the study. You may withdraw from the study at any time for any reason and 
whether you choose to participate or not to participate, it will not reflect on you in anyway. Your 
provider will continue to support you in meeting your health care needs and offer you, as always, 
the highest quality standard of care.  
 
To help ensure your privacy of participation or not, your care providers will not have access to 
any data that they would not have access to if you were not in the study. The researcher will only 
report data as group information with no names attached to report. To help assure no one will 
know anything about your participation, survey answers or day and time you personally filled the 
prescription your name and clinic identification number will not be associated with any 
paperwork for the study. No one will have access to your data except the researcher unless they 
would have access to that information regardless of  if you were in the study or not and need the 
information to provide you quality care in the future. All the documentation related to the project 
including anything that links your name or other identifying information to any documents will 
be stored in a locked and secured cabinet at the urgent care clinic for three years and then be 
shredded.  
 
Benefits for Participation in the Study:  
There is no financial incentive for you to participate in the study. However, as a thank you, the 
clinic will offer you a free of charge ten day follow-up visit if desired and you will be 
contributing to our clinic’s data base as to what interventions are most effective in satisfying for 
you and future subjects that present with an upper respiratory infection. We thank you for your 
time and consideration.  
 
 Alternative Procedures:  
Regardless of your participation or not in the study, your provider will address your health care 
goals and, with you, design a plan of care consistent with current evidence (standard of care) and 
your preferences today and in the future.  
 
Confidentiality if You Elect to Participate: 
Just a reminder, please do NOT write any identifying information on your questionnaire. Today, 
I will collect the first completed questionnaire from you then code it to identify you only to the 
researcher and provide you with code to use for any other documents you complete for the study. 
Every effort will be made to preserve your confidentiality including the following: 
 
• Assigning code names/numbers for participants that will be used on all researcher notes and 
documents. No other identification of participants such as name or clinic identification numbers 
will be on any documents. 
• Any documents with any identifying participant information will be kept in a locked file cabinet 
in the personal possession of the researcher. When no longer necessary for research, all materials 
will be destroyed. 
• The researcher and the members of the researcher’s committee will review the researcher’s 
collected data. Information from this research will be used solely for the purpose of this study 
and any publications that may result from this study. All participants involved in this study will 
not be identified and their anonymity will be maintained.  
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• Participant data will be kept confidential except in cases where the researcher is legally obligated 
to report specific incidents. These incidents include, but may not be limited to, incidents of abuse 
and suicide risk.  
 
 
 
 
 
 
Person to Contact:  
Should you have any questions about the research or any related matters, please contact the 
researcher at  
Name  : Joann Cheah 
Phone   : 301-609-4699 
E-mail  : fcheah@regis.edu 
 
OR  
 
Dr. Lynn Wimett, a nurse practitioner and faculty member overseeing this research project: 
Phone  : 303-458-4063 (W) 
  : 720-203-1366 (C)  
Email  : lwimett@regis.edu 
 
This study was approved by the Regis University Institutional Review Board 
 
If you have questions regarding your rights as a research subject, or if problems arise which you 
do not feel you can discuss with the Investigator, or faculty member, please contact the clinical 
director, Erin Kim CRNP. Phone: 321-868-8313, email: erin.kim@health-first.org.   
 
Regis Institutional Review Board Chair: 
Dr. Margaret Oot-Hayes, PhD, RN 
781-768-7163 
margaret.oot-hayes@regiscollege.edu  
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Consent 
Title of Study: The Difference in Antibiotics Prescriptions Filled between subjects Receiving 
the Delayed Patient-led Prescription Strategy and Those Receiving Delayed Prescription 
Collection Strategy for Uncomplicated Upper Respiratory Infections 
 
Voluntary Participation:  
Your participation in this study is voluntary. It is up to you to decide whether or not to take part 
in this study. If you do decide to take part in this study, you will be asked to sign this consent 
form. If you decide to take part in this study, you are still free to withdraw at any time and 
without giving a reason. You are free to not answer any question or questions if you choose. This 
will not affect the relationship you have with the providers/researcher.  
 
Unforeseeable Risks: 
There may be risks that are not anticipated. However every effort will be made to minimize any 
risks.  
 
Costs To Subject:  
There are no costs to you for your participation in this study. A complementary (free) 10 day 
follow-up appointment is offered to participants if they desire.  
 
Compensation:  
There is no monetary compensation to you for your participation in this study.  
 
Consent:  
By signing this consent form, I confirm that I have read and understood the information and have 
had the opportunity to ask questions. I understand that my participation is voluntary and that I 
am free to withdraw at any time, without giving a reason and without cost. I understand that I 
will be given a copy of this consent form. I voluntarily agree to take part in this study. 
 
Signature:________________________________ 
 
Print Name: 
 
Date: 
 
 
Witness Signature:______________________________ 
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Print Name: 
 
Date:  
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 Appendix G 
Enrollment Sheet 
Number Intervention 1 Intervention 2 
1 Patient ID label  
2   
3   
4   
5   
6   
7   
 
Patient ID label will be placed in the space 
--   Odd number subjects will be assigned to Intervention One 
The first patient enrolled will be 1001, third patient will be 1002 
-- Even number subjects will be assigned to Intervention Two  
The second patient enrolled will be 2001, fourth patient will be 2002 
  --This enrollment sheet contains subjects’ ID and the study participant numbers assigned to the 
subjects. Like all the documentation related to the project, it will be stored in a locked and 
secured cabinet of the urgent care clinic for three years. Only the PI, office manager and care 
providers have access to this documentation. HIPAA is strictly mandated in the urgent care 
clinic. 
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Appendix H 
Follow Up Response Form 
Patient ID:  Intervention Arm: One or Two  Final diagnosis ICD-10: 
 Day 0—at office visit Day 3 Day 7 Day 10 post office 
visit 
Do you believe you 
need antibiotics?  
(before education) 
Same question after 
education 
Y/N 
 
Y/N 
   
Does the education 
material helps with -
1.Understanding of 
your illness and 
progression? 
2.  influence your 
decision of filling the 
antibiotics Rx 
Y/N 
 
 
Y/N 
 
   
Do you believe 
symptomatic treatment 
helps 
   Y/N 
Did pt fill the 
antibiotics Rx? If yes, 
how long did pt wait 
after D0 to fill the Rx?  
How badly do you 
feel?Today? Day 
three? Day seven? Day 
ten? 
(WURSS 21 Score) 
 
 
 
 
Baseline WURSS score  
Today__________ 
 
1. No 
2. Day 1-3 
3. Day 4-6 
4. Day 7-9 
5. Day 10+ 
 
 
 
 
 
 
Day three_______ 
 
1. No 
2. Day 1-3 
3. Day 4-6 
4. Day 7-9 
5. Day 10+ 
 
 
 
 
 
Day seven_______ 
1. No 
2. Day 1-3 
3. Day 4-6 
4. Day 7-9 
5. Day 10+ 
 
 
 
 
 
Day  ten_______ 
Are you satisfied with 
the treatment? 
   0,1,2,3,4,5 
(1-not at all, 5-very 
satisfied) 
Did you seek help at 
another clinic due to 
dissatisfied treatment 
plan? 
   Y/N 
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Appendix I 
Letter of Agreement from Urgent Care Clinic  
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Letter of Agreement from Urgent Care Clinic  
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Appendix J 
Regis University IRB Approval 
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Appendix K 
Get Smart Antibiotic Quiz 
**Do you believe you need antibiotics for your symptoms today? ** 
Yes 
No 
get-smart-antibiotics-quiz : Get Smart Antibiotics Quiz  
Question 1 
Antibiotics fight infections caused by 
Antibiotics  
Bacteria  
Viruses and Bacteria  
Question 2 
Bacteria are germs that cause colds and flu.  
True  
False  
Question 3 
Which of these illnesses should be treated with antibiotics? 
Runny Nose  
The Flu  
Cold  
Strep Throat  
Question 4 
Bacteria that cause infections can become resistant to antibiotics.  
True  
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False  
 
Question 5 
I can prevent antibiotics-resistant infections when I: (hint: More than one may apply) 
don't take an antibiotics for a viral infection  
don't save an antibiotics for the next time I am sick  
don't take an antibiotics prescribed for someone else  
take my antibiotics exactly as my healthcare provider tells me  
Question 6 
What can happen if I get an antibiotics-resistant infection? (hint: More than one may apply) 
I may have a longer-lasting illness  
I may have to visit my doctor more  
I may require hospitalization  
I may need more costly medicine that may cause side effects  
Question 7 
Alexander Fleming discovered the first antibiotics in 1928. What was the antibiotics 
named? 
Mold  
Penicillin  
Vancomycin  
Doxycycline  
Question 8 
Antibiotics resistance has been called one of the world's most pressing public health 
problems. 
True  
False  
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Appendix L 
WURSS-21 
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Appendix M 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Project 
The Difference in Antibiotics Prescriptions Filled between Patients Receiving the Delayed 
Patient-led Prescription Strategy and Those Receiving Delayed Prescription Collection 
Strategy 
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Appendix N 
 
 
 
 
 
 
